BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065-7. [DOI: 10.1038/2053] [Cited by in Crossref: 876] [Cited by in F6Publishing: 814] [Article Influence: 38.1] [Reference Citation Analysis]
Number Citing Articles
1 Ratziu V, Trabut JB, Poynard T. Fat, diabetes, and liver injury in chronic hepatitis C. Curr Gastroenterol Rep. 2004;6:22-29. [PMID: 14720450 DOI: 10.1007/s11894-004-0022-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
2 McLaughlin-Drubin ME, Munger K. Viruses associated with human cancer. Biochim Biophys Acta 2008;1782:127-50. [PMID: 18201576 DOI: 10.1016/j.bbadis.2007.12.005] [Cited by in Crossref: 203] [Cited by in F6Publishing: 149] [Article Influence: 14.5] [Reference Citation Analysis]
3 Adinolfi LE, Rinaldi L, Guerrera B, Restivo L, Marrone A, Giordano M, Zampino R. NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. Int J Mol Sci. 2016;17. [PMID: 27231906 DOI: 10.3390/ijms17060803] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 8.6] [Reference Citation Analysis]
4 Wang F, Yoshida I, Takamatsu M, Ishido S, Fujita T, Oka K, Hotta H. Complex formation between hepatitis C virus core protein and p21Waf1/Cip1/Sdi1. Biochem Biophys Res Commun. 2000;273:479-484. [PMID: 10873631 DOI: 10.1006/bbrc.2000.2970] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 1.9] [Reference Citation Analysis]
5 Urbanowski MD, Ilkow CS, Hobman TC. Modulation of signaling pathways by RNA virus capsid proteins. Cell Signal 2008;20:1227-36. [PMID: 18258415 DOI: 10.1016/j.cellsig.2007.12.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
6 Seo YL, Heo S, Jang KL. Hepatitis C virus core protein overcomes H2O2-induced apoptosis by downregulating p14 expression via DNA methylation. Journal of General Virology 2015;96:822-32. [DOI: 10.1099/vir.0.000032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
7 Yang WT, Wu LW, Tseng TC, Chen CL, Yang HC, Su TH, Wang CC, Kuo SF, Liu CH, Chen PJ. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection. Medicine (Baltimore). 2016;95:e2995. [PMID: 26962809 DOI: 10.1097/md.0000000000002995] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
8 Ma H, Ke C, Hsieh T, Lo S. The first hydrophobic domain of the hepatitis C virus E1 protein is important for interaction with the capsid protein. Journal of General Virology 2002;83:3085-92. [DOI: 10.1099/0022-1317-83-12-3085] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
9 Bozza PT, Melo RC, Bandeira-Melo C. Leukocyte lipid bodies regulation and function: contribution to allergy and host defense. Pharmacol Ther 2007;113:30-49. [PMID: 16945418 DOI: 10.1016/j.pharmthera.2006.06.006] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 5.2] [Reference Citation Analysis]
10 Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002;122:366-75. [DOI: 10.1053/gast.2002.30983] [Cited by in Crossref: 648] [Cited by in F6Publishing: 602] [Article Influence: 34.1] [Reference Citation Analysis]
11 Villani R, Vendemiale G, Serviddio G. Molecular Mechanisms Involved in HCC Recurrence after Direct-Acting Antiviral Therapy. Int J Mol Sci 2018;20:E49. [PMID: 30583555 DOI: 10.3390/ijms20010049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
12 Giambartolomei S, Covone F, Levrero M, Balsano C. Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein. Oncogene. 2001;20:2606-2610. [PMID: 11420671 DOI: 10.1038/sj.onc.1204372] [Cited by in Crossref: 99] [Cited by in F6Publishing: 102] [Article Influence: 5.0] [Reference Citation Analysis]
13 Hosui A, Ohkawa K, Ishida H, Sato A, Nakanishi F, Ueda K, Takehara T, Kasahara A, Sasaki Y, Hori M. Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-gamma stimuli. J Biol Chem. 2003;278:28562-28571. [PMID: 12764155 DOI: 10.1074/jbc.m210485200] [Cited by in Crossref: 51] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
14 Alisi A, Giannini C, Spaziani A, Caini P, Zignego AL, Balsano C. Involvement of PI3K in HCV-related lymphoproliferative disorders. J Cell Physiol 2008;214:396-404. [DOI: 10.1002/jcp.21211] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
15 Brass V, Blum HE, Moradpour D. Of mice and men: a small animal model of hepatitis C virus replication. Hepatology. 2002;35:722-724. [PMID: 11870390 DOI: 10.1053/jhep.2002.0350722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
16 Ben Ari Z, Weitzman E, Safran M. Oncogenic Viruses and Hepatocellular Carcinoma. Clinics in Liver Disease 2015;19:341-60. [DOI: 10.1016/j.cld.2015.01.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
17 Shi ST, Polyak SJ, Tu H, Taylor DR, Gretch DR, Lai MM. Hepatitis C Virus NS5A Colocalizes with the Core Protein on Lipid Droplets and Interacts with Apolipoproteins. Virology 2002;292:198-210. [DOI: 10.1006/viro.2001.1225] [Cited by in Crossref: 216] [Cited by in F6Publishing: 220] [Article Influence: 11.4] [Reference Citation Analysis]
18 Ogawa K, Hishiki T, Shimizu Y, Funami K, Sugiyama K, Miyanari Y, Shimotohno K. Hepatitis C virus utilizes lipid droplet for production of infectious virus. Proc Jpn Acad Ser B Phys Biol Sci 2009;85:217-28. [PMID: 19644222 DOI: 10.2183/pjab.85.217] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
19 Lai MM. Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology. 2002;122:568-571. [PMID: 11832470 DOI: 10.1053/gast.2002.31474] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 4.3] [Reference Citation Analysis]
20 Ray SC, Thomas DL. Hepatitis C. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier; 2010. pp. 2157-85. [DOI: 10.1016/b978-0-443-06839-3.00154-5] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
21 Zemel R, Gerechet S, Greif H, Bachmatove L, Birk Y, Golan-Goldhirsh A, Kunin M, Berdichevsky Y, Benhar I, Tur-Kaspa R. Cell transformation induced by hepatitis C virus NS3 serine protease. J Viral Hepat. 2001;8:96-102. [PMID: 11264729 DOI: 10.1046/j.1365-2893.2001.00283.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 2.7] [Reference Citation Analysis]
22 Khalid A, Hussain T, Manzoor S, Saalim M, Khaliq S. PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma. Tumour Biol 2017;39:101042831770575. [DOI: 10.1177/1010428317705754] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
23 Ohno T, Tanaka Y, Sugauchi F, Orito E, Hasegawa I, Nukaya H, Kato A, Matunaga S, Endo M, Tanaka Y. Suppressive effect of oral administration of branched-chain amino acid granules on oxidative stress and inflammation in HCV-positive patients with liver cirrhosis. Hepatol Res. 2008;38:683-688. [PMID: 18328070 DOI: 10.1111/j.1872-034x.2008.00319.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
24 Machida K, Liu JC, McNamara G, Levine A, Duan L, Lai MM. Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway. J Virol. 2009;83:12590-12600. [PMID: 19793824 DOI: 10.1128/jvi.02643-08] [Cited by in Crossref: 46] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
25 Pessayre D, Fromenty B, Mansouri A. Drug-Induced Microvesicular Steatosis and Steatohepatitis. In: Lemasters JJ, Nieminen A, editors. Mitochondria in Pathogenesis. Boston: Kluwer Academic Publishers; 2002. pp. 489-517. [DOI: 10.1007/0-306-46835-2_26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Chiyo T, Sekiguchi S, Hayashi M, Tobita Y, Kanegae Y, Saito I, Kohara M. Conditional gene expression in hepatitis C virus transgenic mice without induction of severe liver injury using a non-inflammatory Cre-expressing adenovirus. Virus Res. 2011;160:89-97. [PMID: 21645560 DOI: 10.1016/j.virusres.2011.05.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
27 Suhail M, Sohrab SS, Qureshi A, Tarique M, Abdel-Hafiz H, Al-Ghamdi K, Qadri I. Association of HCV mutated proteins and host SNPs in the development of hepatocellular carcinoma. Infect Genet Evol 2018;60:160-72. [PMID: 29501636 DOI: 10.1016/j.meegid.2018.02.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
28 Goh PY, Tan YJ, Lim SP, Lim SG, Tan YH, Hong WJ. The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavage. Virology. 2001;290:224-236. [PMID: 11883187 DOI: 10.1006/viro.2001.1195] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 2.4] [Reference Citation Analysis]
29 Cho JW, Baek WK, Suh SI, Yang SH, Chang J, Sung YC, Suh MH. Hepatitis C virus core protein promotes cell proliferation through the upregulation of cyclin E expression levels. Liver. 2001;21:137-142. [PMID: 11318983 DOI: 10.1034/j.1600-0676.2001.021002137.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.0] [Reference Citation Analysis]
30 Pagano JS, Blaser M, Buendia MA, Damania B, Khalili K, Raab-Traub N, Roizman B. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 2004;14:453-71. [PMID: 15489139 DOI: 10.1016/j.semcancer.2004.06.009] [Cited by in Crossref: 198] [Cited by in F6Publishing: 168] [Article Influence: 12.4] [Reference Citation Analysis]
31 Miller K, McArdle S, Gale MJ Jr, Geller DA, Tenoever B, Hiscott J, Gretch DR, Polyak SJ. Effects of the hepatitis C virus core protein on innate cellular defense pathways. J Interferon Cytokine Res 2004;24:391-402. [PMID: 15296650 DOI: 10.1089/1079990041535647] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]
32 Bartenschlager R, Lohmann V. Replication of hepatitis C virus. J Gen Virol. 2000;81:1631-1648. [PMID: 10859368 DOI: 10.1099/0022-1317-81-7-1631] [Cited by in Crossref: 374] [Cited by in F6Publishing: 426] [Article Influence: 17.8] [Reference Citation Analysis]
33 Tu T, Bühler S, Bartenschlager R. Chronic viral hepatitis and its association with liver cancer. Biol Chem 2017;398:817-37. [PMID: 28455951 DOI: 10.1515/hsz-2017-0118] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 11.8] [Reference Citation Analysis]
34 Guha C, Lee SW, Chowdhury NR, Chowdhury JR. Cell culture models and animal models of viral hepatitis. Part II: hepatitis C. Lab Anim (NY). 2005;34:39-47. [PMID: 15685191 DOI: 10.1038/laban0205-39] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
35 Wakita T, Katsume A, Kato J, Taya C, Yonekawa H, Kanegae Y, Saito I, Hayashi Y, Koike M, Miyamoto M. Possible role of cytotoxic T cells in acute liver injury in hepatitis C virus cDNA transgenic mice mediated by Cre/loxP system. J Med Virol. 2000;62:308-317. [PMID: 11055240 DOI: 10.1002/1096-9071(200011)62:3%3C308::AID-JMV2%3E3.0.CO;2-6] [Reference Citation Analysis]
36 Kurosaki M, Hosokawa T, Matsunaga K, Hirayama I, Tanaka T, Sato M, Yasui Y, Tamaki N, Ueda K, Tsuchiya K. Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy. Hepatol Res. 2010;40:870-877. [PMID: 20887591 DOI: 10.1111/j.1872-034x.2010.00692.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 18] [Article Influence: 5.2] [Reference Citation Analysis]
37 Wang AG, Lee DS, Moon HB, Kim JM, Cho KH, Choi SH, Ha HL, Han YH, Kim DG, Hwang SB. Non-structural 5A protein of hepatitis C virus induces a range of liver pathology in transgenic mice. J Pathol. 2009;219:253-262. [PMID: 19621337 DOI: 10.1002/path.2592] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
38 Tanaka K, Kondoh N, Shuda M, Matsubara O, Imazeki N, Ryo A, Wakatsuki T, Hada A, Goseki N, Igari T. Enhanced expression of mRNAs of antisecretory factor-1, gp96, DAD1 and CDC34 in human hepatocellular carcinomas. Biochim Biophys Acta. 2001;1536:1-12. [PMID: 11335099 DOI: 10.1016/s0925-4439(01)00026-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
39 Fujita N, Takei Y. Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C. J Gastroenterol 2007;42:923-6. [PMID: 18008038 DOI: 10.1007/s00535-007-2110-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
40 Osna NA, Ganesan M, Kharbanda KK. Hepatitis C, innate immunity and alcohol: friends or foes? Biomolecules 2015;5:76-94. [PMID: 25664450 DOI: 10.3390/biom5010076] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
41 Soguero C, Joo M, Chianese-Bullock KA, Nguyen DT, Tung K, Hahn YS. Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model. J Virol 2002;76:9345-54. [PMID: 12186917 DOI: 10.1128/jvi.76.18.9345-9354.2002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
42 Bode JG, Brenndörfer ED, Häussinger D. Subversion of innate host antiviral strategies by the hepatitis C virus. Arch Biochem Biophys. 2007;462:254-265. [PMID: 17467654 DOI: 10.1016/j.abb.2007.03.033] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
43 Shimizu I, Impact of oestrogens on the progression of liver disease Liver Int. 2003;23:63-69. [PMID: 12640729 DOI: 10.1034/j.1600-0676.2003.00811.x] [Cited by in Crossref: 136] [Cited by in F6Publishing: 115] [Article Influence: 7.6] [Reference Citation Analysis]
44 Saito T, Sugimoto M, Okumoto K, Haga H, Katsumi T, Mizuno K, Nishina T, Sato S, Igarashi K, Maki H, Tomita M, Ueno Y, Soga T. Serum metabolome profiles characterized by patients with hepatocellular carcinoma associated with hepatitis B and C. World J Gastroenterol. 2016;22:6224-6234. [PMID: 27468212 DOI: 10.3748/wjg.v22.i27.6224] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
45 Goto K, Roca Suarez AA, Wrensch F, Baumert TF, Lupberger J. Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip. Int J Mol Sci. 2020;21. [PMID: 32357520 DOI: 10.3390/ijms21093057] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
46 Guo L, Sharma SD, Debes JD, Beisang D, Rattenbacher B, Vlasova-St Louis I, Wiesner DL, Cameron CE, Bohjanen PR. The hepatitis C viral nonstructural protein 5A stabilizes growth-regulatory human transcripts. Nucleic Acids Res 2018;46:2537-47. [PMID: 29385522 DOI: 10.1093/nar/gky061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
47 Aizaki H, Harada T, Otsuka M, Seki N, Matsuda M, Li YW, Kawakami H, Matsuura Y, Miyamura T, Suzuki T. Expression profiling of liver cell lines expressing entire or parts of hepatitis C virus open reading frame: Expression Profiling of Liver Cell Lines Expressing Entire or Parts of Hepatitis C Virus Open Reading Frame. Hepatology 2002;36:1431-8. [DOI: 10.1002/hep.1840360620] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
48 Mitchell JK, Lemon SM, McGivern DR. How do persistent infections with hepatitis C virus cause liver cancer? Curr Opin Virol. 2015;14:101-108. [PMID: 26426687 DOI: 10.1016/j.coviro.2015.09.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
49 Hsu Y, Wu C, Lin J. Hepatitis C Virus Infection, Antiviral Therapy, and Risk of Hepatocellular Carcinoma. Seminars in Oncology 2015;42:329-38. [DOI: 10.1053/j.seminoncol.2014.12.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
50 Wu WB, Shao SW, Zhao LJ, Luan J, Cao J, Gao J, Zhu SY, Qi ZT. Hepatitis C virus F protein up-regulates c-myc and down-regulates p53 in human hepatoma HepG2 cells. Intervirology. 2007;50:341-346. [PMID: 17700029 DOI: 10.1159/000107271] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
51 Hayashi PH, Di Bisceglie AM. The progression of hepatitis B– and C–infections to chronic liver disease and hepatocellular carcinoma: epidemiology and pathogenesis. Medical Clinics of North America 2005;89:371-89. [DOI: 10.1016/j.mcna.2004.08.014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
52 Feitelson MA, Larkin JD. New animal models of hepatitis B and C. ILAR J. 2001;42:127-138. [PMID: 11406715 DOI: 10.1093/ilar.42.2.127] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
53 Delgado-Borrego A, Kamegaya Y, Jordan SH, Agrawal S, Valim C, Chung RT. HCV synergizes with body weight in the promotion of insulin resistance. J Viral Hepat 2011;18:135-41. [PMID: 20497310 DOI: 10.1111/j.1365-2893.2010.01291.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
54 Pang R, Tse E, Poon RT. Molecular pathways in hepatocellular carcinoma. Cancer Lett. 2006;240:157-169. [PMID: 16239065 DOI: 10.1016/j.canlet.2005.08.031] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 3.9] [Reference Citation Analysis]
55 Park SH, Lim JS, Lim SY, Tiwari I, Jang KL. Hepatitis C virus Core protein stimulates cell growth by down-regulating p16 expression via DNA methylation. Cancer Lett 2011;310:61-8. [PMID: 21757290 DOI: 10.1016/j.canlet.2011.06.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
56 Imazeki F, Yokosuka O, Fukai K, Hiraide A, Saisho H. Significance of prior hepatitis B virus infection in the development of hepatocellular carcinoma in patients with chronic hepatitis C. Dig Dis Sci 2003;48:1786-92. [PMID: 14561002 DOI: 10.1023/a:1025459431613] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
57 Kato N, Yoshida H, Kioko Ono-nita S, Kato J, Goto T, Otsuka M, Lan K, Matsushima K, Shiratori Y, Omata M. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology 2000;32:405-12. [DOI: 10.1053/jhep.2000.9198] [Cited by in Crossref: 142] [Cited by in F6Publishing: 138] [Article Influence: 6.8] [Reference Citation Analysis]
58 Moriishi K, Matsuura Y. Host factors involved in the replication of hepatitis C virus. Rev Med Virol 2007;17:343-54. [DOI: 10.1002/rmv.542] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
59 Tsuchihara K, Hijikata M, Fukuda K, Kuroki T, Yamamoto N, Shimotohno K. Hepatitis C Virus Core Protein Regulates Cell Growth and Signal Transduction Pathway Transmitting Growth Stimuli. Virology 1999;258:100-7. [DOI: 10.1006/viro.1999.9694] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 3.6] [Reference Citation Analysis]
60 Uranbileg B, Enooku K, Soroida Y, Ohkawa R, Kudo Y, Nakagawa H, Tateishi R, Yoshida H, Shinzawa S, Moriya K, Ohtomo N, Nishikawa T, Inoue Y, Tomiya T, Kojima S, Matsuura T, Koike K, Yatomi Y, Ikeda H. High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential. Int J Cancer 2014;134:2189-98. [PMID: 24174293 DOI: 10.1002/ijc.28547] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
61 Wang Y, Jiang Y, Zhou J, Song W, Li J, Wang M, Chen J, Xu R, Zhang J, Ma F, Chen YH, Ma Y. Hepatitis C virus promotes hepatocellular carcinogenesis by targeting TIPE2, a new regulator of DNA damage response. Tumour Biol 2016;37:15265-74. [PMID: 27696294 DOI: 10.1007/s13277-016-5409-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
62 Méndez-sánchez; N, Vásquez-fernández; F, Zamora-valdés; D, Uribe M. Sorafenib, a systemic therapy for hepatocellular carcinoma. Annals of Hepatology 2008;7:46-51. [DOI: 10.1016/s1665-2681(19)31886-1] [Cited by in Crossref: 23] [Article Influence: 1.8] [Reference Citation Analysis]
63 Xu S, Pei R, Guo M, Han Q, Lai J, Wang Y, Wu C, Zhou Y, Lu M, Chen X. Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assembly. J Virol 2012;86:13025-37. [PMID: 23015700 DOI: 10.1128/JVI.01785-12] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
64 Carbone M, Barbanti-brodano G. Viral Carcinogenesis. In: Chang AE, Hayes DF, Pass HI, Stone RM, Ganz PA, Kinsella TJ, Schiller JH, Strecher VJ, editors. Oncology. New York: Springer; 2006. pp. 214-32. [DOI: 10.1007/0-387-31056-8_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Kasprzak A, Adamek A. Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis. Hepatol Res. 2008;38:1-26. [PMID: 17894800 DOI: 10.1111/j.1872-034x.2007.00261.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
66 Lim JS, Park SH, Jang KL. Hepatitis C virus Core protein overcomes stress-induced premature senescence by down-regulating p16 expression via DNA methylation. Cancer Lett 2012;321:154-61. [PMID: 22326283 DOI: 10.1016/j.canlet.2012.01.044] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
67 Miyamoto H, Moriishi K, Moriya K, Murata S, Tanaka K, Suzuki T, Miyamura T, Koike K, Matsuura Y. Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein. J Virol. 2007;81:1727-1735. [PMID: 17135326 DOI: 10.1128/jvi.01683-06] [Cited by in Crossref: 89] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
68 Hirashima N, Matsumoto Y, Ohono T, Kimura Y, Hasegawa I, Ueda R. Hepatic Fas protein expression might be a predictive factor for hepatocellular carcinoma development in patients with chronic hepatitis C undergoing interferon therapy. J Clin Gastroenterol 2002;34:263-7. [PMID: 11873109 DOI: 10.1097/00004836-200203000-00014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
69 Saito M, Seo Y, Yano Y, Miki A, Morinaga Y, Itoh T, Yoshida M, Azuma T. Development of a hepatocellular carcinoma in a chronic hepatitis C patient 18 years after achieving a sustained virological response to interferon therapy: case report and literature review. Clin J Gastroenterol 2012;5:119-26. [DOI: 10.1007/s12328-012-0284-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
70 Baek KH, Park HY, Kang CM, Kim SJ, Jeong SJ, Hong EK, Park JW, Sung YC, Suzuki T, Kim CM. Overexpression of hepatitis C virus NS5A protein induces chromosome instability via mitotic cell cycle dysregulation. J Mol Biol. 2006;359:22-34. [PMID: 16616934 DOI: 10.1016/j.jmb.2006.03.020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
71 Chiba T, Suzuki E, Saito T, Ogasawara S, Ooka Y, Tawada A, Iwama A, Yokosuka O. Biological features and biomarkers in hepatocellular carcinoma. World J Hepatol. 2015;7:2020-2028. [PMID: 26261691 DOI: 10.4254/wjh.v7.i16.2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
72 Nischalke HD, Coenen M, Berger C, Aldenhoff K, Müller T, Berg T, Krämer B, Körner C, Odenthal M, Schulze F. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C. Int J Cancer. 2012;130:1470-1475. [PMID: 21500195 DOI: 10.1002/ijc.26143] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
73 Arora P, Basu A, Schmidt ML, Clark GJ, Donninger H, Nichols DB, Calvisi DF, Kaushik-Basu N. Nonstructural protein 5B promotes degradation of the NORE1A tumor suppressor to facilitate hepatitis C virus replication. Hepatology 2017;65:1462-77. [PMID: 28090674 DOI: 10.1002/hep.29049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
74 Madejón A, Sheldon J, Francisco-Recuero I, Perales C, Domínguez-Beato M, Lasa M, Sánchez-Perez I, Muntané J, Domingo E, García-Samaniego J, Sánchez-Pacheco A. Hepatitis C virus-mediated Aurora B kinase inhibition modulates inflammatory pathway and viral infectivity. J Hepatol 2015;63:312-9. [PMID: 25733156 DOI: 10.1016/j.jhep.2015.02.036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
75 Donato MF, Degott C, Arosio E, Martinot M, Monti V, Morabito A, Marcellin P, Colombo M. Interferon-alpha suppresses liver cell proliferation in patients with chronic hepatitis C virus infection. J Viral Hepat 2005;12:499-506. [DOI: 10.1111/j.1365-2893.2005.00625.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
76 You J, Hou S, Malik-Soni N, Xu Z, Kumar A, Rachubinski RA, Frappier L, Hobman TC. Flavivirus Infection Impairs Peroxisome Biogenesis and Early Antiviral Signaling. J Virol 2015;89:12349-61. [PMID: 26423946 DOI: 10.1128/JVI.01365-15] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
77 Berggren KA, Suzuki S, Ploss A. Animal Models Used in Hepatitis C Virus Research. Int J Mol Sci 2020;21:E3869. [PMID: 32485887 DOI: 10.3390/ijms21113869] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
78 Meuleman P, Leroux-Roels G. HCV animal models: a journey of more than 30 years. Viruses 2009;1:222-40. [PMID: 21994547 DOI: 10.3390/v1020222] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
79 Isom HC, McDevitt EI, Moon MS. Elevated hepatic iron: a confounding factor in chronic hepatitis C. Biochim Biophys Acta. 2009;1790:650-662. [PMID: 19393721 DOI: 10.1016/j.bbagen.2009.04.009] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
80 Tian Y, Yang Y, Zhang X, Nakajima T, Tanaka N, Sugiyama E, Kamijo Y, Lu Y, Moriya K, Koike K, Gonzalez FJ, Aoyama T. Age-dependent PPARα activation induces hepatic sulfatide accumulation in transgenic mice carrying the hepatitis C virus core gene. Glycoconj J 2016;33:927-36. [PMID: 27318478 DOI: 10.1007/s10719-016-9703-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
81 Kanda T, Goto T, Hirotsu Y, Moriyama M, Omata M. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review. Int J Mol Sci. 2019;20. [PMID: 30889843 DOI: 10.3390/ijms20061358] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 29.5] [Reference Citation Analysis]
82 Sato Y, Kato J, Takimoto R, Takada K, Kawano Y, Miyanishi K, Kobune M, Sato Y, Takayama T, Matunaga T, Niitsu Y. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB. Gut 2006;55:1801-8. [PMID: 16581947 DOI: 10.1136/gut.2005.070417] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 4.5] [Reference Citation Analysis]
83 Kang SM, Kim SJ, Kim JH, Lee W, Kim GW, Lee KH, Choi KY, Oh JW. Interaction of hepatitis C virus core protein with Hsp60 triggers the production of reactive oxygen species and enhances TNF-alpha-mediated apoptosis. Cancer Lett. 2009;279:230-237. [PMID: 19264393 DOI: 10.1016/j.canlet.2009.02.003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
84 Liu Z, Ma W, Li H, Li Q. Clinicopathological and prognostic features of primary clear cell carcinoma of the liver. Hepatol Res. 2008;38:291-299. [PMID: 17877725 DOI: 10.1111/j.1872-034x.2007.00264.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
85 Rawlinson SM, Moseley GW. The nucleolar interface of RNA viruses. Cell Microbiol 2015;17:1108-20. [DOI: 10.1111/cmi.12465] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 6.5] [Reference Citation Analysis]
86 Colombo M. Hepatocellular carcinoma in patients with HCV. Best Practice & Research Clinical Gastroenterology 2000;14:327-39. [DOI: 10.1053/bega.1999.0079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
87 Villanueva A, Hernandez-Gea V, Llovet JM. Medical therapies for hepatocellular carcinoma: a critical view of the evidence. Nat Rev Gastroenterol Hepatol. 2013;10:34-42. [PMID: 23147664 DOI: 10.1038/nrgastro.2012.199] [Cited by in Crossref: 210] [Cited by in F6Publishing: 200] [Article Influence: 23.3] [Reference Citation Analysis]
88 Suzuki T, Ishii K, Aizaki H, Wakita T. Hepatitis C viral life cycle. Adv Drug Deliv Rev. 2007;59:1200-1212. [PMID: 17825945 DOI: 10.1016/j.addr.2007.04.014] [Cited by in Crossref: 96] [Cited by in F6Publishing: 85] [Article Influence: 6.9] [Reference Citation Analysis]
89 Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. J Viral Hepat. 2005;12:635-641. [PMID: 16255765 DOI: 10.1111/j.1365-2893.2005.00635.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
90 Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Alcohol Clin Exp Res. 2003;27:47S-51S. [PMID: 12960507 DOI: 10.1097/01.alc.0000079449.47468.b0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
91 Lyn RK, Kennedy DC, Sagan SM, Blais DR, Rouleau Y, Pegoraro AF, Xie XS, Stolow A, Pezacki JP. Direct imaging of the disruption of hepatitis C virus replication complexes by inhibitors of lipid metabolism. Virology 2009;394:130-42. [DOI: 10.1016/j.virol.2009.08.022] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
92 Shan Y, Chen X, Huang B, Hu A, Xiao D, Guo Z. Malignant transformation of the cultured human hepatocytes induced by hepatitis C virus core protein: Malignant transformation of the cultured human hepatocytes. Liver International 2005;25:141-7. [DOI: 10.1111/j.1478-3231.2005.0999.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
93 Tasaka-Fujita M, Sugiyama N, Kang W, Masaki T, Murayama A, Yamada N, Sugiyama R, Tsukuda S, Watashi K, Asahina Y, Sakamoto N, Wakita T, Shin EC, Kato T. Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression. Sci Rep 2015;5:13994. [PMID: 26365522 DOI: 10.1038/srep13994] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
94 Rullier A, Trimoulet P, Urbaniak R, Winnock M, Zauli D, Ballardini G, Rosenbaum J, Balabaud C, Bioulac-Sage P, Le Bail B. Immunohistochemical detection of hcv in cirrhosis, dysplastic nodules, and hepatocellular carcinomas with parallel-tissue quantitative RT-PCR. Mod Pathol 2001;14:496-505. [PMID: 11353061 DOI: 10.1038/modpathol.3880338] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
95 Koshiyama A, Ichibangase T, Moriya K, Koike K, Yazawa I, Imai K. Liquid chromatographic separation of proteins derivatized with a fluorogenic reagent at cysteinyl residues on a non-porous column for differential proteomics analysis. Journal of Chromatography A 2011;1218:3447-52. [DOI: 10.1016/j.chroma.2011.03.070] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
96 Yagi S, Mori K, Shiota K. Implications of the HCV subgenome discovery for viral pathogenesis, persistence and proliferation. Future Virology 2006;1:425-33. [DOI: 10.2217/17460794.1.4.425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
97 Soe K, Hishikawa Y, Fukuzawa Y, Win N, Yin KS, Win KM, Myint AA, Koji T. Possible correlation between iron deposition and enhanced proliferating activity in hepatitis C virus-positive hepatocellular carcinoma in Myanmar (Burma). J Gastroenterol 2007;42:225-35. [PMID: 17380281 DOI: 10.1007/s00535-006-1993-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
98 Wieland SF, Chisari FV. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol. 2005;79:9369-9380. [PMID: 16014900 DOI: 10.1128/jvi.79.15.9369-9380.2005] [Cited by in Crossref: 303] [Cited by in F6Publishing: 153] [Article Influence: 18.9] [Reference Citation Analysis]
99 Tanaka N, Moriya K, Kiyosawa K, Koike K, Aoyama T. Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis. Int J Cancer. 2008;122:124-131. [PMID: 17764115 DOI: 10.1002/ijc.23056] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 3.8] [Reference Citation Analysis]
100 Kim GW, Imam H, Khan M, Mir SA, Kim SJ, Yoon SK, Hur W, Siddiqui A. HBV-Induced Increased N6 Methyladenosine Modification of PTEN RNA Affects Innate Immunity and Contributes to HCC. Hepatology 2021;73:533-47. [PMID: 32394474 DOI: 10.1002/hep.31313] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
101 Dharancy S, Malapel M, Perlemuter G, Roskams T, Cheng Y, Dubuquoy L, Podevin P, Conti F, Canva V, Philippe D, Gambiez L, Mathurin P, Paris J, Schoonjans K, Calmus Y, Pol S, Auwerx J, Desreumaux P. Impaired expression of the peroxisome proliferator–activated receptor alpha during hepatitis C virus infection. Gastroenterology 2005;128:334-42. [DOI: 10.1053/j.gastro.2004.11.016] [Cited by in Crossref: 140] [Cited by in F6Publishing: 138] [Article Influence: 8.8] [Reference Citation Analysis]
102 Goossens N, Hoshida Y. Hepatitis C virus-induced hepatocellular carcinoma. Clin Mol Hepatol. 2015;21:105-114. [PMID: 26157746 DOI: 10.3350/cmh.2015.21.2.105] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 13.3] [Reference Citation Analysis]
103 Heindryckx F, Colle I, Van Vlierberghe H. Experimental mouse models for hepatocellular carcinoma research. Int J Exp Pathol. 2009;90:367-386. [PMID: 19659896 DOI: 10.1111/j.1365-2613.2009.00656.x] [Cited by in Crossref: 232] [Cited by in F6Publishing: 198] [Article Influence: 19.3] [Reference Citation Analysis]
104 Liu B, Ma X, Wang Q, Luo S, Zhang L, Wang W, Fu Y, Allain JP, Li C, Li T. Marmoset Viral Hepatic Inflammation Induced by Hepatitis C Virus Core Protein via IL-32. Front Cell Infect Microbiol 2020;10:135. [PMID: 32373543 DOI: 10.3389/fcimb.2020.00135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
105 Camus G, Vogt DA, Kondratowicz AS, Ott M. Lipid droplets and viral infections. Methods Cell Biol 2013;116:167-90. [PMID: 24099293 DOI: 10.1016/B978-0-12-408051-5.00009-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
106 Tan Y, Li Y. HCV core protein promotes hepatocyte proliferation and chemoresistance by inhibiting NR4A1. Biochem Biophys Res Commun 2015;466:592-8. [PMID: 26392314 DOI: 10.1016/j.bbrc.2015.09.091] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
107 Griffith AS, Hayashi PH, Burke LM, McRee AJ. Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance. J Hepatocell Carcinoma 2018;5:55-9. [PMID: 29911076 DOI: 10.2147/JHC.S152569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
108 Park TJ, Jeong BR, Tateno C, Kim HS, Ogawa T, Lim IK, Yoshizato K. Pleiotrophin inhibits transforming growth factor beta1-induced apoptosis in hepatoma cell lines. Mol Carcinog 2008;47:784-96. [PMID: 18381592 DOI: 10.1002/mc.20438] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
109 Chiu CM, Yeh SH, Chen PJ, Kuo TJ, Chang CJ, Yang WJ, Chen DS. Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc Natl Acad Sci U S A. 2007;104:2571-2578. [PMID: 17259306 DOI: 10.1073/pnas.0609498104] [Cited by in Crossref: 95] [Cited by in F6Publishing: 96] [Article Influence: 6.8] [Reference Citation Analysis]
110 Nakai K, Okamoto T, Kimura-Someya T, Ishii K, Lim CK, Tani H, Matsuo E, Abe T, Mori Y, Suzuki T, Miyamura T, Nunberg JH, Moriishi K, Matsuura Y. Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein. J Virol 2006;80:11265-73. [PMID: 16971440 DOI: 10.1128/JVI.01203-06] [Cited by in Crossref: 43] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
111 Yoshida K, Matsuzaki K, Murata M, Yamaguchi T, Suwa K, Okazaki K. Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis. Cancers (Basel) 2018;10:E183. [PMID: 29874844 DOI: 10.3390/cancers10060183] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 9.7] [Reference Citation Analysis]
112 Bassendine MF, Sheridan DA, Bridge SH, Felmlee DJ, Neely RDG. Lipids and HCV. Semin Immunopathol 2013;35:87-100. [DOI: 10.1007/s00281-012-0356-2] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 7.8] [Reference Citation Analysis]
113 Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am J Pathol 2002;160:641-54. [PMID: 11839585 DOI: 10.1016/S0002-9440(10)64884-5] [Cited by in Crossref: 133] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
114 Khaliq S, Jahan S, Pervaiz A. Sequence variability of HCV Core region: Important predictors of HCV induced pathogenesis and viral production. Infection, Genetics and Evolution 2011;11:543-56. [DOI: 10.1016/j.meegid.2011.01.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
115 Hoshida Y, Fuchs BC, Bardeesy N, Baumert TF, Chung RT. Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma. J Hepatol. 2014;61:S79-S90. [PMID: 25443348 DOI: 10.1016/j.jhep.2014.07.010] [Cited by in Crossref: 124] [Cited by in F6Publishing: 104] [Article Influence: 17.7] [Reference Citation Analysis]
116 Zekry A, McHutchison JG, Diehl AM. Insulin resistance and steatosis in hepatitis C virus infection. Gut 2005;54:903-6. [PMID: 15951532 DOI: 10.1136/gut.2004.059873] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
117 Nash KL, Woodall T, Brown AS, Davies SE, Alexander GJ. Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis. World J Gastroenterol 2010;16:4061-5. [PMID: 20731020 DOI: 10.3748/wjg.v16.i32.4061] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
118 Seren S, Mutchnick M, Hutchinson D, Harmanci O, Bayraktar Y, Mutchnick S, Sahin K, Kucuk O. Potential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma. Nutr Cancer 2008;60:729-35. [PMID: 19005972 DOI: 10.1080/01635580802419772] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
119 Tumurbaatar B, Sun Y, Chan T, Sun J. Cre-estrogen receptor-mediated hepatitis C virus structural protein expression in mice. J Virol Methods. 2007;146:5-13. [PMID: 17628708 DOI: 10.1016/j.jviromet.2007.05.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
120 Russo MW. Antiviral therapy for hepatitis C is associated with improved clinical outcomes in patients with advanced fibrosis. Expert Rev Gastroenterol Hepatol. 2010;4:535-539. [PMID: 20932138 DOI: 10.1586/egh.10.60] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
121 Yamaguchi A, Tazuma S, Nishioka T, Ohishi W, Hyogo H, Nomura S, Chayama K. Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver. Dig Dis Sci. 2005;50:1361-1371. [PMID: 16047488 DOI: 10.1007/s10620-005-2788-1] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 4.4] [Reference Citation Analysis]
122 Ariyasu T, Tanaka T, Fujioka N, Yanai Y, Yamamoto S, Yamauchi H, Ikegami H, Ikeda M, Kurimoto M. Effects of interferon-alpha subtypes on the TH1/TH2 balance in peripheral blood mononuclear cells from patients with hepatitis virus infection-associated liver disorders. In Vitro Cell Dev Biol Anim. 2005;41:50-56. [PMID: 15926860 DOI: 10.1290/0501008.1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
123 Mirandola S, Bowman D, Hussain MM, Alberti A. Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP). Nutr Metab (Lond) 2010;7:13. [PMID: 20178560 DOI: 10.1186/1743-7075-7-13] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
124 Banerjee A, Ray RB, Ray R. Oncogenic potential of hepatitis C virus proteins. Viruses. 2010;2:2108-2133. [PMID: 21994721 DOI: 10.3390/v2092108] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 6.9] [Reference Citation Analysis]
125 El-Zayadi AR, Anis M. Hepatitis C virus induced insulin resistance impairs response to anti viral therapy. World J Gastroenterol 2012;18:212-24. [PMID: 22294824 DOI: 10.3748/wjg.v18.i3.212] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
126 Fujie H, Yotsuyanagi H, Moriya K, Shintani Y, Tsutsumi T, Takayama T, Makuuchi M, Matsuura Y, Miyamura T, Kimura S, Koike K. Steatosis and intrahepatic hepatitis C virus in chronic hepatitis. J Med Virol 1999;59:141-5. [DOI: 10.1002/(sici)1096-9071(199910)59:2<141::aid-jmv3>3.0.co;2-5] [Cited by in Crossref: 74] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
127 Arora P, Kim EO, Jung JK, Jang KL. Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b. Cancer Lett 2008;261:244-52. [PMID: 18164808 DOI: 10.1016/j.canlet.2007.11.033] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 5.9] [Reference Citation Analysis]
128 Werling K, Szentirmay Z, Szepesi A, Schaff Z, Szalay F, Szabó Z, Telegdy L, Dávid K, Stotz G, Tulassay Z. Hepatocyte proliferation and cell cycle phase fractions in chronic viral hepatitis C by image analysis method. Eur J Gastroenterol Hepatol 2001;13:489-93. [PMID: 11396526 DOI: 10.1097/00042737-200105000-00005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
129 Miyatake H, Kobayashi Y, Iwasaki Y, Nakamura S, Ohnishi H, Kuwaki K, Toshimori J, Hagihara H, Nouso K, Yamamoto K. Effect of Previous Interferon Treatment on Outcome After Curative Treatment for Hepatitis C Virus-Related Hepatocellular Carcinoma. Dig Dis Sci 2012;57:1092-101. [DOI: 10.1007/s10620-011-1934-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
130 Ashfaq UA, Javed T, Rehman S, Nawaz Z, Riazuddin S. Inhibition of HCV 3a core gene through Silymarin and its fractions. Virol J. 2011;8:153. [PMID: 21453551 DOI: 10.1186/1743-422x-8-153] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
131 Benegiamo G, Vinciguerra M, Mazzoccoli G, Piepoli A, Andriulli A, Pazienza V. DNA methyltransferases 1 and 3b expression in Huh-7 cells expressing HCV core protein of different genotypes. Dig Dis Sci 2012;57:1598-603. [PMID: 22526584 DOI: 10.1007/s10620-012-2160-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
132 Irshad M, Gupta P, Irshad K. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection. World J Hepatol. 2017;9:1305-1314. [PMID: 29359013 DOI: 10.4254/wjh.v9.i36.1305] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
133 Dou J, Liu P, Wang J, Zhang X. Effect of hepatitis C virus core shadow protein expressed in human hepatoma cell line on human gene expression profiles. J Gastroenterol Hepatol 2006;21:1794-800. [DOI: 10.1111/j.1440-1746.2006.04380.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
134 Yen TS. Nuclear factor kappaB and hepatitis C--Is there a connection. Hepatology. 2000;31:785-787. [PMID: 10706574 DOI: 10.1002/hep.510310334] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
135 Karthe J, Tessmann K, Li J, Machida R, Daleman M, Häussinger D, Heintges T. Specific targeting of hepatitis C virus core protein by an intracellular single-chain antibody of human origin. Hepatology 2008;48:702-12. [PMID: 18697213 DOI: 10.1002/hep.22366] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
136 Dash S, Haque S, Joshi V, Prabhu R, Hazari S, Fermin C, Garry R. HCV-hepatocellular carcinoma: new findings and hope for effective treatment. Microsc Res Tech 2005;68:130-48. [PMID: 16276514 DOI: 10.1002/jemt.20227] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
137 Sato S, Fukasawa M, Yamakawa Y, Natsume T, Suzuki T, Shoji I, Aizaki H, Miyamura T, Nishijima M. Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein. J Biochem 2006;139:921-30. [PMID: 16751600 DOI: 10.1093/jb/mvj104] [Cited by in Crossref: 131] [Cited by in F6Publishing: 125] [Article Influence: 8.7] [Reference Citation Analysis]
138 Herrero Martínez E. Hepatitis B and hepatitis C co-infection in patients with HIV. Rev Med Virol 2001;11:253-70. [PMID: 11479931 DOI: 10.1002/rmv.323] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
139 McLauchlan J. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J Viral Hepat. 2000;7:2-14. [PMID: 10718937 DOI: 10.1046/j.1365-2893.2000.00201.x] [Cited by in Crossref: 217] [Cited by in F6Publishing: 207] [Article Influence: 10.3] [Reference Citation Analysis]
140 Bartenschlager R, Frese M, Pietschmann T. Novel insights into hepatitis C virus replication and persistence. Adv Virus Res. 2004;63:71-180. [PMID: 15530561 DOI: 10.1016/s0065-3527(04)63002-8] [Cited by in Crossref: 207] [Cited by in F6Publishing: 102] [Article Influence: 12.9] [Reference Citation Analysis]
141 Adinolfi LE, Restivo L, Marrone A. The predictive value of steatosis in hepatitis C virus infection. Expert Rev Gastroenterol Hepatol. 2013;7:205-213. [PMID: 23445230 DOI: 10.1586/egh.13.7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
142 Kobayashi M, Suzuki F, Fujiyama S, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kumada H. Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection: DAA Reduces Incidence of HCC in Patients With HCV. J Med Virol 2017;89:476-83. [DOI: 10.1002/jmv.24663] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 15.0] [Reference Citation Analysis]
143 Fukuhara T, Takeishi K, Toshima T, Morita K, Ueda S, Iguchi T, Nagata S, Sugimachi K, Ikegami T, Gion T. Impact of amino acid substitutions in the core region of HCV on multistep hepatocarcinogenesis. Hepatol Res. 2010;40:171-178. [PMID: 19788689 DOI: 10.1111/j.1872-034x.2009.00575.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
144 Iwasa S, Sato N, Wang CW, Cheng YH, Irokawa H, Hwang GW, Naganuma A, Kuge S. The Phospholipid:Diacylglycerol Acyltransferase Lro1 Is Responsible for Hepatitis C Virus Core-Induced Lipid Droplet Formation in a Yeast Model System. PLoS One 2016;11:e0159324. [PMID: 27459103 DOI: 10.1371/journal.pone.0159324] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
145 Mueller S, Afdhal NH, Schuppan D. Iron, HCV, and liver cancer: hard metal setting the pace? Gastroenterology. 2006;130:2229-2234. [PMID: 16762645 DOI: 10.1053/j.gastro.2006.05.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
146 Kim KH, Hong SP, Kim K, Park MJ, Kim KJ, Cheong J. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. Biochem Biophys Res Commun. 2007;355:883-888. [PMID: 17331464 DOI: 10.1016/j.bbrc.2007.02.044] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 6.8] [Reference Citation Analysis]
147 Zhao Y, Qin W, Zhang JP, Hu ZY, Tong JW, Ding CB, Peng ZG, Zhao LX, Song DQ, Jiang JD. HCV IRES-mediated core expression in zebrafish. PLoS One. 2013;8:e56985. [PMID: 23469178 DOI: 10.1371/journal.pone.0056985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
148 Della Corte C, Aghemo A, Colombo M. Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies. World J Gastroenterol 2013;19:1359-71. [PMID: 23538741 DOI: 10.3748/wjg.v19.i9.1359] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
149 Franco J, Saeian K. Role of Antiviral Therapy in the Prevention of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2002;13:S191-6. [DOI: 10.1016/s1051-0443(07)61786-2] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
150 Frelin L, Brenndörfer ED, Ahlén G, Weiland M, Hultgren C, Alheim M, Glaumann H, Rozell B, Milich DR, Bode JG. The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor alpha mediated liver disease. Gut. 2006;55:1475-1483. [PMID: 16527836 DOI: 10.1136/gut.2005.085050] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
151 Koga H. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors? Cancer. 2003;98:661-667. [PMID: 12910508 DOI: 10.1002/cncr.11576] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
152 Wang AG, Moon HB, Chun SY, Lee TH, Yu DY, Lee DS. Orchiectomy reduces hepatotumorigenesis of H-ras12V transgenic mice via the MAPK pathway. Life Sci 2006;79:1974-80. [PMID: 16846616 DOI: 10.1016/j.lfs.2006.06.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
153 Moriishi K, Mochizuki R, Moriya K, Miyamoto H, Mori Y, Abe T, Murata S, Tanaka K, Miyamura T, Suzuki T. Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci USA. 2007;104:1661-1666. [PMID: 17234812 DOI: 10.1073/pnas.0607312104] [Cited by in Crossref: 142] [Cited by in F6Publishing: 135] [Article Influence: 10.1] [Reference Citation Analysis]
154 Bartenschlager R, Lohmann V. Replication of the hepatitis C virus. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:241-254. [PMID: 10890319 DOI: 10.1053/bega.1999.0073] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 1.9] [Reference Citation Analysis]
155 Kanda T, Jiang X, Yokosuka O. Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers. World J Gastroenterol. 2014;20:9229-9236. [PMID: 25071315 DOI: 10.3748/wjg.v20.i28.9229] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
156 Tornillo L, Carafa V, Richter J, Sauter G, Moch H, Minola E, Gambacorta M, Bianchi L, Vecchione R, Terracciano LM. Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas. J Pathol 2000;192:307-12. [PMID: 11054713 DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH706>3.0.CO;2-O] [Cited by in Crossref: 45] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
157 Weng WK, Levy S. Hepatitis C virus (HCV) and lymphomagenesis. Leuk Lymphoma. 2003;44:1113-1120. [PMID: 12916862 DOI: 10.1080/1042819031000076972] [Cited by in Crossref: 67] [Cited by in F6Publishing: 53] [Article Influence: 3.7] [Reference Citation Analysis]
158 Omori Y, Imai J, Watanabe M, Komatsu T, Suzuki Y, Kataoka K, Watanabe S, Tanigami A, Sugano S. CREB-H: a novel mammalian transcription factor belonging to the CREB/ATF family and functioning via the box-B element with a liver-specific expression. Nucleic Acids Res 2001;29:2154-62. [PMID: 11353085 DOI: 10.1093/nar/29.10.2154] [Cited by in Crossref: 110] [Cited by in F6Publishing: 102] [Article Influence: 5.5] [Reference Citation Analysis]
159 Wang TH, Rijnbrand RC, Lemon SM. Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. J Virol. 2000;74:11347-11358. [PMID: 11070035 DOI: 10.1128/jvi.74.23.11347-11358.2000] [Cited by in Crossref: 66] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
160 Nault JC. Pathogenesis of hepatocellular carcinoma according to aetiology. Best Pract Res Clin Gastroenterol. 2014;28:937-947. [PMID: 25260319 DOI: 10.1016/j.bpg.2014.08.006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
161 Tsuji M, Takenaka R, Kashihara T, Hadama T, Terada N, Mori H. Primary hepatic leiomyosarcoma in a patient with hepatitis C virus-related liver cirrhosis. Pathol Int. 2000;50:41-47. [PMID: 10692176 DOI: 10.1046/j.1440-1827.2000.00999.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
162 Wang M, Han J, Xing H, Zhang H, Li Z, Liang L, Li C, Dai S, Wu M, Shen F, Yang T. Dysregulated fatty acid metabolism in hepatocellular carcinoma. Hepat Oncol 2016;3:241-51. [PMID: 30191046 DOI: 10.2217/hep-2016-0012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
163 Kubo S, Tamori A, Ohba K, Shuto T, Yamamoto T, Tanaka H, Nishiguchi S, Wakasa K, Hirohashi K, Kinoshita H. Previous or occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma without hepatic fibrosis. Dig Dis Sci. 2001;46:2408-2414. [PMID: 11713944 DOI: 10.1023/a:1012359400193] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
164 Mirandola S, Realdon S, Iqbal J, Gerotto M, Dal Pero F, Bortoletto G, Marcolongo M, Vario A, Datz C, Hussain MM, Alberti A. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. Gastroenterology. 2006;130:1661-1669. [PMID: 16697730 DOI: 10.1053/j.gastro.2006.02.035] [Cited by in Crossref: 143] [Cited by in F6Publishing: 130] [Article Influence: 9.5] [Reference Citation Analysis]
165 Blonsky JJ, Harrison SA. Review article: nonalcoholic fatty liver disease and hepatitis C virus--partners in crime. Aliment Pharmacol Ther 2008;27:855-65. [PMID: 18315584 DOI: 10.1111/j.1365-2036.2008.03672.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
166 Cha C, Dematteo RP. Molecular mechanisms in hepatocellular carcinoma development. Best Pract Res Clin Gastroenterol. 2005;19:25-37. [PMID: 15757803 DOI: 10.1016/j.bpg.2004.11.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 4.1] [Reference Citation Analysis]
167 Gale M, Beard MR. Molecular clones of hepatitis C virus: applications to animal models. ILAR J. 2001;42:139-151. [PMID: 11406716 DOI: 10.1093/ilar.42.2.139] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
168 Schuppan D, Krebs A, Bauer M, Hahn EG. Hepatitis C and liver fibrosis. Cell Death Differ 2003;10:S59-67. [DOI: 10.1038/sj.cdd.4401163] [Cited by in Crossref: 140] [Cited by in F6Publishing: 133] [Article Influence: 7.8] [Reference Citation Analysis]
169 Merle P. [Epidemiology, natural history and pathogenesis of hepatocellular carcinoma]. Cancer Radiother 2005;9:452-7. [PMID: 16226912 DOI: 10.1016/j.canrad.2005.09.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
170 Giménez-barcons M, Wang C, Chen M, Sánchez-tapias J, Sáiz J, Gale M. The Oncogenic Potential of Hepatitis C Virus NS5A Sequence Variants Is Associated with PKR Regulation. Journal of Interferon & Cytokine Research 2005;25:152-64. [DOI: 10.1089/jir.2005.25.152] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
171 Chung CZ, Balasuriya N, Manni E, Liu X, Li SS, O'Donoghue P, Heinemann IU. Gld2 activity is regulated by phosphorylation in the N-terminal domain. RNA Biol 2019;16:1022-33. [PMID: 31057087 DOI: 10.1080/15476286.2019.1608754] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
172 Liu C. Hepatitis C Virus: Virology and Experimental Systems. Clinics in Liver Disease 2006;10:773-91. [DOI: 10.1016/j.cld.2006.08.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
173 Chang MY, Chen JC, Yeh CT, Chiu CT, Lin DY, Chang ML. The various impacts of the hepatitis C virus core protein upon hepatic oxidative stress after common bile duct ligation and partial hepatectomy. Redox Rep 2008;13:172-8. [PMID: 18647487 DOI: 10.1179/135100008X259277] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
174 Berson A, Gervais A, Cazals D, Boyer N, Durand F, Bernuau J, Marcellin P, Degott C, Valla D, Pessayre D. Hepatitis after intravenous buprenorphine misuse in heroin addicts. Journal of Hepatology 2001;34:346-50. [DOI: 10.1016/s0168-8278(00)00049-0] [Cited by in Crossref: 62] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
175 Lin YL, Li Y. Study on the hepatocellular carcinoma model with metastasis. Genes Dis 2020;7:336-50. [PMID: 32884988 DOI: 10.1016/j.gendis.2019.12.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
176 Erhardt A, Hassan M, Heintges T, Häussinger D. Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line. Virology. 2002;292:272-284. [PMID: 11878930 DOI: 10.1006/viro.2001.1227] [Cited by in Crossref: 92] [Cited by in F6Publishing: 92] [Article Influence: 4.8] [Reference Citation Analysis]
177 Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, Uemura Y, Sakaida N, Fujisawa J, Seki T, Kobayashi K, Yokote K, Koike K, Okazaki K. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-β signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Hepatology 2009;49:1203-17. [DOI: 10.1002/hep.22765] [Cited by in Crossref: 108] [Cited by in F6Publishing: 107] [Article Influence: 8.3] [Reference Citation Analysis]
178 Blum HE, Moradpour D. Viral pathogenesis of hepatocellular carcinoma. J Gastroenterol Hepatol. 2002;17 Suppl 3:S413-S420. [PMID: 12472973 DOI: 10.1046/j.1440-1746.17.s3.37.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
179 Wu Q, Li Z, Liu Q. Treatment with PTEN-Long protein inhibits hepatitis C virus replication. Virology 2017;511:1-8. [PMID: 28783500 DOI: 10.1016/j.virol.2017.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
180 He QQ, Cheng RX, Sun Y, Feng DY, Chen ZC, Zheng H. Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 c-terminal deleted protein. World J Gastroenterol. 2003;9:474-478. [PMID: 12632500 DOI: 10.3748/wjg.v9.i3.474] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
181 Lee H, Ainechi S, Dresser K, Kurian EM. Central portalization correlates with fibrosis but not with risk factors for nonalcoholic steatohepatitis in steatotic chronic hepatitis C. Int J Hepatol 2014;2014:329297. [PMID: 25525520 DOI: 10.1155/2014/329297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
182 Nada O, Abdel-Hamid M, Ismail A, El Shabrawy L, Sidhom KF, El Badawy NM, Ghazal FA, El Daly M, El Kafrawy S, Esmat G, Loffredo CA. The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma. J Clin Virol 2005;34:140-6. [PMID: 16157266 DOI: 10.1016/j.jcv.2005.02.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
183 Alisi A, Giannini C, Spaziani A, Anticoli S, Caini P, Zignego AL, Balsano C. Hepatitis C virus core protein enhances B lymphocyte proliferation. Dig Liver Dis 2007;39 Suppl 1:S72-5. [PMID: 17936228 DOI: 10.1016/s1590-8658(07)80015-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
184 Suzuki R, Tamura K, Li J, Ishii K, Matsuura Y, Miyamura T, Suzuki T. Ubiquitin-mediated degradation of hepatitis C virus core protein is regulated by processing at its carboxyl terminus. Virology. 2001;280:301-309. [PMID: 11162844 DOI: 10.1006/viro.2000.0785] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 2.5] [Reference Citation Analysis]
185 Pazienza V, Panebianco C, Andriulli A. Hepatitis viruses exploitation of host DNA methyltransferases functions. Clin Exp Med 2016;16:265-72. [PMID: 26148656 DOI: 10.1007/s10238-015-0372-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
186 Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol. 2008;14:4300-4308. [PMID: 18666317 DOI: 10.3748/wjg.v14.i27.4300] [Reference Citation Analysis]
187 Moustafa S, Karakasiliotis I, Mavromara P. Hepatitis C Virus core+1/ARF Protein Modulates the Cyclin D1/pRb Pathway and Promotes Carcinogenesis. J Virol 2018;92:e02036-17. [PMID: 29444947 DOI: 10.1128/JVI.02036-17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
188 Yamanaka T, Uchida M, Doi T. Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein. Biochem Biophys Res Commun 2002;294:521-7. [PMID: 12056797 DOI: 10.1016/S0006-291X(02)00507-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
189 Miyoshi H, Fujie H, Shintani Y, Tsutsumi T, Shinzawa S, Makuuchi M, Kokudo N, Matsuura Y, Suzuki T, Miyamura T. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression. J Hepatol. 2005;43:757-763. [PMID: 16083990 DOI: 10.1016/j.jhep.2005.03.028] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
190 Tsai WL, Chung RT. Viral hepatocarcinogenesis. Oncogene 2010;29:2309-24. [PMID: 20228847 DOI: 10.1038/onc.2010.36] [Cited by in Crossref: 184] [Cited by in F6Publishing: 164] [Article Influence: 16.7] [Reference Citation Analysis]
191 Ohkoshi S, Hirono H, Watanabe K, Hasegawa K, Yano M. Contributions of transgenic mouse studies on the research of hepatitis B virus and hepatitis C virus-induced hepatocarcinogenesis. World J Hepatol 2015;7:2834-40. [PMID: 26668695 DOI: 10.4254/wjh.v7.i28.2834] [Reference Citation Analysis]
192 El-Shamy A, Hotta H. Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview. World J Gastroenterol. 2014;20:7555-7569. [PMID: 24976696 DOI: 10.3748/wjg.v20.i24.7555] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
193 Machida K. TLRs, Alcohol, HCV, and Tumorigenesis. Gastroenterol Res Pract. 2010;2010:518674. [PMID: 21331379 DOI: 10.1155/2010/518674] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
194 Vercauteren K, de Jong YP, Meuleman P. HCV animal models and liver disease. J Hepatol 2014;61:S26-33. [PMID: 25443343 DOI: 10.1016/j.jhep.2014.07.013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
195 Smith AJ, Smith LA. Viral Carcinogenesis. Prog Mol Biol Transl Sci 2016;144:121-68. [PMID: 27865457 DOI: 10.1016/bs.pmbts.2016.09.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
196 Ma HC, Lin TW, Li H, Iguchi-Ariga SM, Ariga H, Chuang YL, Ou JH, Lo SY. Hepatitis C virus ARFP/F protein interacts with cellular MM-1 protein and enhances the gene trans-activation activity of c-Myc. J Biomed Sci. 2008;15:417-425. [PMID: 18398700 DOI: 10.1007/s11373-008-9248-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
197 Ishikawa T, Shibuya K, Yasui K, Mitamura K, Ueda S. Expression of hepatitis C virus core protein associated with malignant lymphoma in transgenic mice. Comp Immunol Microbiol Infect Dis. 2003;26:115-124. [PMID: 12493492 DOI: 10.1016/s0147-9571(02)00038-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
198 Vassilaki N, Mavromara P. The HCV ARFP/F/core+1 protein: production and functional analysis of an unconventional viral product. IUBMB Life. 2009;61:739-752. [PMID: 19548320 DOI: 10.1002/iub.201] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
199 Seitz HK, Stickel F. Ethanol and Hepatocarcinogenesis. In: Watson RR, Preedy VR, Zibadi S, editors. Alcohol, Nutrition, and Health Consequences. Totowa: Humana Press; 2013. pp. 411-27. [DOI: 10.1007/978-1-62703-047-2_32] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
200 Shimizu I, Ito S. Protection of estrogens against the progression of chronic liver disease. Hepatol Res. 2007;37:239-247. [PMID: 17397511 DOI: 10.1111/j.1872-034x.2007.00032.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 28] [Article Influence: 6.9] [Reference Citation Analysis]
201 Hassany SM, Hassan W, Abo-Alam H, Khalaf M, Nafeh AM, Nasr-Eldin E, Mostafa EF. Direct-Acting Antiviral Drugs and Occurrence of Hepatocellular Carcinoma: Unjust or Oppressed. Infect Drug Resist 2020;13:1873-80. [PMID: 32606836 DOI: 10.2147/IDR.S241948] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Koike K. Role of hepatitis viruses in multistep hepatocarcinogenesis. Digestive and Liver Disease 2001;33:2-6. [DOI: 10.1016/s1590-8658(01)80126-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
203 Koike K. Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies. J Gastroenterol. 2002;37 Suppl 13:55-64. [PMID: 12109667 DOI: 10.1007/bf02990101] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
204 Kobayashi S, Matsushita K, Saigo K, Urashima T, Asano T, Hayashi H, Ochiai T. P21WAF1/CIP1 messenger RNA expression in hepatitis B, C virus-infected human hepatocellular carcinoma tissues. Cancer. 2001;91:2096-2103. [PMID: 11391590 DOI: 10.1002/1097-0142(20010601)91:11%3C2096::AID-CNCR1237%3E3.0.CO;2-9] [Reference Citation Analysis]
205 Enooku K, Kondo M, Fujiwara N, Sasako T, Shibahara J, Kado A, Okushin K, Fujinaga H, Tsutsumi T, Nakagomi R, Minami T, Sato M, Nakagawa H, Kondo Y, Asaoka Y, Tateishi R, Ueki K, Ikeda H, Yoshida H, Moriya K, Yotsuyanagi H, Kadowaki T, Fukayama M, Koike K. Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients. J Gastroenterol 2018;53:1261-75. [PMID: 29749571 DOI: 10.1007/s00535-018-1472-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
206 Donlin MJ, Lomonosova E, Kiss A, Cheng X, Cao F, Curto TM, Di Bisceglie A, Tavis JE. HCV genome-wide genetic analyses in context of disease progression and hepatocellular carcinoma. PLoS One 2014;9:e103748. [PMID: 25079603 DOI: 10.1371/journal.pone.0103748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
207 Rekha RD, Amali AA, Her GM, Yeh YH, Gong HY, Hu SY, Lin GH, Wu JL. Thioacetamide accelerates steatohepatitis, cirrhosis and HCC by expressing HCV core protein in transgenic zebrafish Danio rerio. Toxicology. 2008;243:11-22. [PMID: 17997003 DOI: 10.1016/j.tox.2007.09.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
208 Lee MN, Jung EY, Kwun HJ, Jun HK, Yu D, Choi YH, Jang KL. Hepatitis C virus core protein represses the p21 promoter through inhibition of a TGF-β pathway. Journal of General Virology 2002;83:2145-51. [DOI: 10.1099/0022-1317-83-9-2145] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
209 Staib F, Hussain SP, Hofseth LJ, Wang XW, Harris CC. TP53 and liver carcinogenesis. Hum Mutat. 2003;21:201-216. [PMID: 12619106 DOI: 10.1002/humu.10176] [Cited by in Crossref: 157] [Cited by in F6Publishing: 147] [Article Influence: 8.7] [Reference Citation Analysis]
210 Cao Y, Hamada T, Matsui T, Date T, Iwabuchi K. Hepatitis C virus core protein interacts with p53-binding protein, 53BP2/Bbp/ASPP2, and inhibits p53-mediated apoptosis. Biochem Biophys Res Commun. 2004;315:788-795. [PMID: 14985081 DOI: 10.1016/j.bbrc.2004.01.124] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
211 Minamoto T, Mai M, Ronai Z. Environmental factors as regulators and effectors of multistep carcinogenesis. Carcinogenesis 1999;20:519-27. [PMID: 10223177 DOI: 10.1093/carcin/20.4.519] [Cited by in Crossref: 73] [Cited by in F6Publishing: 56] [Article Influence: 3.3] [Reference Citation Analysis]
212 Konishi M, Iwasa M, Araki J, Kobayashi Y, Katsuki A, Sumida Y, Nakagawa N, Kojima Y, Watanabe S, Adachi Y. Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. J Gastroenterol Hepatol. 2006;21:1821-1825. [PMID: 17074020 DOI: 10.1111/j.1440-1746.2006.04420.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 4.4] [Reference Citation Analysis]
213 Valenti L, Pulixi E, La Spina S. IL28B, HCV core mutations, and hepatocellular carcinoma: does host genetic make-up shape viral evolution in response to immunity? Hepatol Int. 2012;6:356-359. [PMID: 26201341 DOI: 10.1007/s12072-011-9327-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
214 Newell P, Villanueva A, Friedman SL, Koike K, Llovet JM. Experimental models of hepatocellular carcinoma. J Hepatol. 2008;48:858-879. [PMID: 18314222 DOI: 10.1016/j.jhep.2008.01.008] [Cited by in Crossref: 150] [Cited by in F6Publishing: 135] [Article Influence: 11.5] [Reference Citation Analysis]
215 Rocchi E, Casalgrandi G, Ronzoni A, Rosa MC, Cioni G, Marazzi A, Manenti A, Marchini S, Ventura E. Antioxidant liposoluble vitamins and carotenoids in chronic hepatitis. Eur J Intern Med 2001;12:116-21. [PMID: 11297914 DOI: 10.1016/s0953-6205(01)00118-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
216 Noh DH, Lee EJ, Kim AY, Lee EM, Min CW, Kang KK, Lee MM, Kim SH, Sung SE, Hwang M, Yu DY, Jeong KS. Alcohol induced hepatic degeneration in a hepatitis C virus core protein transgenic mouse model. Int J Mol Sci 2014;15:4126-41. [PMID: 24608925 DOI: 10.3390/ijms15034126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
217 Kasprzak A, Seidel J, Biczysko W, Wysocki J, Spachacz R, Zabel M. Intracellular localization of NS3 and C proteins in chronic hepatitis C. Liver Int 2005;25:896-903. [PMID: 15998442 DOI: 10.1111/j.1478-3231.2005.01109.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
218 Leyssen P, De Clercq E, Neyts J. Perspectives for the treatment of infections with Flaviviridae. Clin Microbiol Rev 2000;13:67-82, table of contents. [PMID: 10627492 DOI: 10.1128/CMR.13.1.67] [Cited by in Crossref: 83] [Article Influence: 4.0] [Reference Citation Analysis]
219 Pawlotsky J. Le virus de l’hépatite C. Med Sci (Paris) 2002;18:303-14. [DOI: 10.1051/medsci/2002183303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
220 Irshad M, Dhar I. Hepatitis C virus core protein: an update on its molecular biology, cellular functions and clinical implications. Med Princ Pract. 2006;15:405-416. [PMID: 17047346 DOI: 10.1159/000095485] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
221 Mohsen AH, Easterbrook P, Taylor CB, Norris S. Hepatitis C and HIV-1 coinfection. Gut 2002;51:601-8. [PMID: 12235089 DOI: 10.1136/gut.51.4.601] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 3.2] [Reference Citation Analysis]
222 Liu CJ, Kao JH. Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors. J Chin Med Assoc. 2007;70:141-145. [PMID: 17475593 DOI: 10.1016/s1726-4901(09)70346-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
223 Abe R, Okano JI, Imamoto R, Fujise Y, Murawaki Y. Sequential analysis of diethylnitrosamine-induced hepatocarcinogenesis in rats. Exp Ther Med 2012;3:371-8. [PMID: 22969898 DOI: 10.3892/etm.2011.419] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
224 Ripoli M, Pazienza V. Impact of HCV genetic differences on pathobiology of disease. Expert Rev Anti Infect Ther 2011;9:747-59. [PMID: 21905784 DOI: 10.1586/eri.11.94] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
225 Liu D, Wu J, Liu M, Yin H, He J, Zhang B. Downregulation of miRNA-30c and miR-203a is associated with hepatitis C virus core protein-induced epithelial-mesenchymal transition in normal hepatocytes and hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2015;464:1215-1221. [PMID: 26210453 DOI: 10.1016/j.bbrc.2015.07.107] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
226 Zheng Y, Shimamoto S, Maruno T, Kobayashi Y, Matsuura Y, Kawahara K, Yoshida T, Ohkubo T. N-terminal HCV core protein fragment decreases 20S proteasome activity in the presence of PA28γ. Biochem Biophys Res Commun 2019;509:590-5. [PMID: 30602418 DOI: 10.1016/j.bbrc.2018.12.167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
227 Forns X, Purcell RH, Bukh J. Quasispecies in viral persistence and pathogenesis of hepatitis C virus. Trends Microbiol. 1999;7:402-410. [PMID: 10498948 DOI: 10.1016/S0966-842X(99)01590-5] [Cited by in Crossref: 96] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
228 Tan A, Yeh S, Liu C, Cheung C, Chen P. Viral hepatocarcinogenesis: from infection to cancer: Viral hepatocarcinogenesis. Liver International 2008;28:175-88. [DOI: 10.1111/j.1478-3231.2007.01652.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 5.9] [Reference Citation Analysis]
229 Cha S, Park I, Jang KL. Hepatitis C virus core protein activates proteasomal activator 28 gamma to downregulate p16 levels via ubiquitin-independent proteasomal degradation.Heliyon. 2021;7:e06134. [PMID: 33553768 DOI: 10.1016/j.heliyon.2021.e06134] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
230 Rusyn I, Lemon SM. Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies? Cancer Lett. 2014;345:210-215. [PMID: 23871966 DOI: 10.1016/j.canlet.2013.06.028] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
231 Schwer B, Ren S, Pietschmann T, Kartenbeck J, Kaehlcke K, Bartenschlager R, Yen TS, Ott M. Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. J Virol. 2004;78:7958-7968. [PMID: 15254168 DOI: 10.1128/jvi.78.15.7958-7968.2004] [Cited by in Crossref: 118] [Cited by in F6Publishing: 66] [Article Influence: 6.9] [Reference Citation Analysis]
232 Shirakura M, Murakami K, Ichimura T, Suzuki R, Shimoji T, Fukuda K, Abe K, Sato S, Fukasawa M, Yamakawa Y. E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein. J Virol. 2007;81:1174-1185. [PMID: 17108031 DOI: 10.1128/jvi.01684-06] [Cited by in Crossref: 88] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
233 Papatheodoridis GV, Papadimitropoulos VC, Hadziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis. Aliment Pharmacol Ther. 2001;15:689-698. [PMID: 11328263 DOI: 10.1046/j.1365-2036.2001.00979.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 79] [Article Influence: 4.8] [Reference Citation Analysis]
234 Pietschmann T, Bartenschlager R. Tissue culture and animal models for hepatitis C virus. Clinics in Liver Disease 2003;7:23-43. [DOI: 10.1016/s1089-3261(02)00071-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
235 Jiao J, Wang J, Sallberg M. Effects of HCV proteins in current HCV transgenic models. Hepatology Research 2010;40:115-24. [DOI: 10.1111/j.1872-034x.2009.00574.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
236 Feitelson MA, Sun B, Lale Satiroglu Tufan N, Liu J, Pan J, Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002;21:2593-604. [DOI: 10.1038/sj.onc.1205434] [Cited by in Crossref: 238] [Cited by in F6Publishing: 205] [Article Influence: 12.5] [Reference Citation Analysis]
237 Jahan S, Khaliq S, Siddiqi MH, Ijaz B, Ahmad W, Ashfaq UA, Hassan S. Anti-apoptotic effect of HCV core gene of genotype 3a in Huh-7 cell line. Virol J 2011;8:522. [PMID: 22108100 DOI: 10.1186/1743-422X-8-522] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
238 Moon J, Kaowinn S, Cho IR, Min DS, Myung H, Oh S, Kaewpiboon C, Kraemer OH, Chung YH. Hepatitis C virus core protein enhances hepatocellular carcinoma cells to be susceptible to oncolytic vesicular stomatitis virus through down-regulation of HDAC4. Biochem Biophys Res Commun 2016;474:428-34. [PMID: 27150631 DOI: 10.1016/j.bbrc.2016.05.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
239 Jeannot E, Boorman GA, Kosyk O, Bradford BU, Shymoniak S, Tumurbaatar B, Weinman SA, Melnyk SB, Tryndyak V, Pogribny IP. Increased incidence of aflatoxin B1-induced liver tumors in hepatitis virus C transgenic mice. Int J Cancer. 2012;130:1347-1356. [PMID: 21500192 DOI: 10.1002/ijc.26140] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
240 Tien Kuo M, Savaraj N. Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers. Mol Carcinog. 2006;45:701-709. [PMID: 16652372 DOI: 10.1002/mc.20240] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
241 McKillop IH, Moran DM, Jin X, Koniaris LG. Molecular pathogenesis of hepatocellular carcinoma. J Surg Res. 2006;136:125-135. [PMID: 17023002 DOI: 10.1016/j.jss.2006.04.013] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 5.1] [Reference Citation Analysis]
242 Williamson CD, Colberg-Poley AM. Access of viral proteins to mitochondria via mitochondria-associated membranes. Rev Med Virol. 2009;19:147-164. [PMID: 19367604 DOI: 10.1002/rmv.611] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
243 Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. J Med Virol. 2003;71:492-498. [PMID: 14556260 DOI: 10.1002/jmv.10514] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
244 Ivanyi-nagy R, Darlix J. Fuzziness in the Core of the Human Pathogenic Viruses HCV and HIV. In: Fuxreiter M, Tompa P, editors. Fuzziness. New York: Springer US; 2012. pp. 142-58. [DOI: 10.1007/978-1-4614-0659-4_9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
245 Fujisawa H, Kurrer M, Reis RM, Yonekawa Y, Kleihues P, Ohgaki H. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Am J Pathol 1999;155:387-94. [PMID: 10433932 DOI: 10.1016/S0002-9440(10)65135-8] [Cited by in Crossref: 80] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
246 Chang ML, Yeh CT, Lin DY, Ho YP, Hsu CM, Bissell DM. Hepatic inflammation mediated by hepatitis C virus core protein is ameliorated by blocking complement activation. BMC Med Genomics 2009;2:51. [PMID: 19664232 DOI: 10.1186/1755-8794-2-51] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
247 Bantel H, Schulze-osthoff K. Apoptosis in hepatitis C virus infection. Cell Death Differ 2003;10:S48-58. [DOI: 10.1038/sj.cdd.4401119] [Cited by in Crossref: 110] [Cited by in F6Publishing: 111] [Article Influence: 6.1] [Reference Citation Analysis]
248 Choi J. Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic considerations. Free Radic Biol Med. 2012;52:1135-1150. [PMID: 22306508 DOI: 10.1016/j.freeradbiomed.2012.01.008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
249 Reed KE, Rice CM. Overview of Hepatitis C Virus Genome Structure, Polyprotein Processing, and Protein Properties. In: Hagedorn CH, Rice CM, editors. The Hepatitis C Viruses. Berlin: Springer Berlin Heidelberg; 2000. pp. 55-84. [DOI: 10.1007/978-3-642-59605-6_4] [Cited by in Crossref: 89] [Cited by in F6Publishing: 220] [Article Influence: 4.2] [Reference Citation Analysis]
250 Yoshida T, Hanada T, Tokuhisa T, Kosai K, Sata M, Kohara M, Yoshimura A. Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J Exp Med. 2002;196:641-653. [PMID: 12208879 DOI: 10.1084/jem.20012127] [Cited by in Crossref: 189] [Cited by in F6Publishing: 185] [Article Influence: 9.9] [Reference Citation Analysis]
251 Hwang SJ, Lee SD. Hepatic steatosis and hepatitis C: Still unhappy bedfellows? J Gastroenterol Hepatol. 2011;26 Suppl 1:96-101. [PMID: 21199519 DOI: 10.1111/j.1440-1746.2010.06542.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
252 Diao P, Wang X, Jia F, Kimura T, Hu X, Shirotori S, Nakamura I, Sato Y, Nakayama J, Moriya K, Koike K, Gonzalez FJ, Aoyama T, Tanaka N. A saturated fatty acid-rich diet enhances hepatic lipogenesis and tumorigenesis in HCV core gene transgenic mice. J Nutr Biochem 2020;85:108460. [PMID: 32992072 DOI: 10.1016/j.jnutbio.2020.108460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
253 Asahina Y, Tsuchiya K, Tamaki N, Hirayama I, Tanaka T, Sato M, Yasui Y, Hosokawa T, Ueda K, Kuzuya T. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection. Hepatology. 2010;52:518-527. [PMID: 20683951 DOI: 10.1002/hep.23691] [Cited by in Crossref: 198] [Cited by in F6Publishing: 165] [Article Influence: 18.0] [Reference Citation Analysis]
254 Torres HA, Shigle TL, Hammoudi N, Link JT, Samaniego F, Kaseb A, Mallet V. The oncologic burden of hepatitis C virus infection: A clinical perspective. CA Cancer J Clin. 2017;67:411-431. [PMID: 28683174 DOI: 10.3322/caac.21403] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 12.3] [Reference Citation Analysis]
255 De Maria N, Manno M, Villa E. Sex hormones and liver cancer. Mol Cell Endocrinol. 2002;193:59-63. [PMID: 12161002 DOI: 10.1016/s0303-7207(02)00096-5] [Cited by in Crossref: 107] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
256 Ohkawa K, Ishida H, Nakanishi F, Hosui A, Ueda K, Takehara T, Hori M, Hayashi N. Hepatitis C virus core functions as a suppressor of cyclin-dependent kinase-activating kinase and impairs cell cycle progression. J Biol Chem. 2004;279:11719-11726. [PMID: 14711830 DOI: 10.1074/jbc.m308560200] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
257 Naganuma A, Nozaki A, Tanaka T, Sugiyama K, Takagi H, Mori M, Shimotohno K, Kato N. Activation of the interferon-inducible 2'-5'-oligoadenylate synthetase gene by hepatitis C virus core protein. J Virol 2000;74:8744-50. [PMID: 10954577 DOI: 10.1128/jvi.74.18.8744-8750.2000] [Cited by in Crossref: 56] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
258 Samsa MM, Mondotte JA, Iglesias NG, Assunção-Miranda I, Barbosa-Lima G, Da Poian AT, Bozza PT, Gamarnik AV. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog 2009;5:e1000632. [PMID: 19851456 DOI: 10.1371/journal.ppat.1000632] [Cited by in Crossref: 360] [Cited by in F6Publishing: 322] [Article Influence: 30.0] [Reference Citation Analysis]
259 Chang ML, Yeh CT, Chen JC, Huang CC, Lin SM, Sheen IS, Tai DI, Chu CM, Lin WP, Chang MY. Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis. BMC Genomics. 2008;9:109. [PMID: 18307821 DOI: 10.1186/1471-2164-9-109] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
260 Hikita H, Kodama T, Shimizu S, Li W, Shigekawa M, Tanaka S, Hosui A, Miyagi T, Tatsumi T, Kanto T, Hiramatsu N, Morii E, Hayashi N, Takehara T. Bak deficiency inhibits liver carcinogenesis: a causal link between apoptosis and carcinogenesis. J Hepatol 2012;57:92-100. [PMID: 22414765 DOI: 10.1016/j.jhep.2012.01.027] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
261 Billerbeck E, de Jong Y, Dorner M, de la Fuente C, Ploss A. Animal models for hepatitis C. Curr Top Microbiol Immunol. 2013;369:49-86. [PMID: 23463197 DOI: 10.1007/978-3-642-27340-7_3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 49] [Article Influence: 3.0] [Reference Citation Analysis]
262 Jung EY, Kang HK, Chang J, Yu DY, Jang KL. Cooperative transformation of murine fibroblast NIH3T3 cells by hepatitis C virus core protein and hepatitis B virus X protein. Virus Res. 2003;94:79-84. [PMID: 12902036 DOI: 10.1016/s0168-1702(03)00135-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
263 Rigopoulou EI, Dalekos GN. Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases. Cancers (Basel) 2021;13:1023. [PMID: 33804480 DOI: 10.3390/cancers13051023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
264 Wang Y. Scotomas in molecular virology and epidemiology of hepatitis C virus. World J Gastroenterol 2013;19:7910-21. [PMID: 24307785 DOI: 10.3748/wjg.v19.i44.7910] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
265 Ashfaq UA, Masoud MS, Nawaz Z, Riazuddin S. Glycyrrhizin as antiviral agent against Hepatitis C Virus. J Transl Med. 2011;9:112. [PMID: 21762538 DOI: 10.1186/1479-5876-9-112] [Cited by in Crossref: 100] [Cited by in F6Publishing: 76] [Article Influence: 10.0] [Reference Citation Analysis]
266 Powell EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. Hepatology. 2005;42:5-13. [PMID: 15962320 DOI: 10.1002/hep.20750] [Cited by in Crossref: 250] [Cited by in F6Publishing: 232] [Article Influence: 15.6] [Reference Citation Analysis]
267 Okanoue T, Itoh Y, Minami M, Sakamoto S, Yasui K, Sakamoto M, Nishioji K, Murakami Y, Kashima K. Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Journal of Hepatology 1999;30:653-9. [DOI: 10.1016/s0168-8278(99)80196-2] [Cited by in Crossref: 158] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
268 Nair S, Shiv Kumar K, Thuluvath PJ. Mortality from hepatocellular and biliary cancers: changing epidemiological trends. Am J Gastroenterol 2002;97:167-71. [PMID: 11808943 DOI: 10.1111/j.1572-0241.2002.05432.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
269 Sharp GB, Lagarde F, Mizuno T, Sauvaget C, Fukuhara T, Allen N, Suzuki G, Tokuoka S. Relationship of hepatocellular carcinoma to soya food consumption: A cohort-based, case-control study in Japan. Int J Cancer 2005;115:290-5. [DOI: 10.1002/ijc.20897] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
270 Mercer DF. Animal models for studying hepatitis C and alcohol effects on liver. World J Gastroenterol. 2011;17:2515-2519. [PMID: 21633656 DOI: 10.3748/wjg.v17.i20.2515] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
271 Lagging LM, Garcia CE, Westin J, Wejstål R, Norkrans G, Dhillon AP, Lindh M. Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time. J Clin Microbiol 2002;40:4224-9. [PMID: 12409402 DOI: 10.1128/JCM.40.11.4224-4229.2002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
272 Moriya K, Todoroki T, Tsutsumi T, Fujie H, Shintani Y, Miyoshi H, Ishibashi K, Takayama T, Makuuchi M, Watanabe K. Increase in the concentration of carbon 18 monounsaturated fatty acids in the liver with hepatitis C: analysis in transgenic mice and humans. Biochem Biophys Res Commun. 2001;281:1207-1212. [PMID: 11243863 DOI: 10.1006/bbrc.2001.4523] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 2.7] [Reference Citation Analysis]
273 He L, Tian DA, Li PY, He XX. Mouse models of liver cancer: Progress and recommendations. Oncotarget 2015;6:23306-22. [PMID: 26259234 DOI: 10.18632/oncotarget.4202] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 10.0] [Reference Citation Analysis]
274 Ko E, Kim SJ, Joh JW, Park CK, Park J, Kim DH. CpG island hypermethylation of SOCS-1 gene is inversely associated with HBV infection in hepatocellular carcinoma. Cancer Lett 2008;271:240-50. [PMID: 18639978 DOI: 10.1016/j.canlet.2008.06.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
275 Ogata S, Nagano-Fujii M, Ku Y, Yoon S, Hotta H. Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma. J Clin Microbiol. 2002;40:3625-3630. [PMID: 12354856 DOI: 10.1128/jcm.40.10.3625-3630.2002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
276 Hung CH, Chen CH, Lee CM, Wu CM, Hu TH, Wang JH, Yen YH, Lu SN. Association of amino acid variations in the NS5A and E2-PePHD region of hepatitis C virus 1b with hepatocellular carcinoma. J Viral Hepat 2008;15:58-65. [PMID: 18088246 DOI: 10.1111/j.1365-2893.2007.00892.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 0.1] [Reference Citation Analysis]
277 Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chrétien Y, Koike K, Pessayre D, Chapman J, Barba G. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J. 2002;16:185-194. [PMID: 11818366 DOI: 10.1096/fj.01-0396com] [Cited by in Crossref: 401] [Cited by in F6Publishing: 389] [Article Influence: 21.1] [Reference Citation Analysis]
278 Chitapanarux T, Phornphutkul K. Risk Factors for the Development of Hepatocellular Carcinoma in Thailand. J Clin Transl Hepatol 2015;3:182-8. [PMID: 26623264 DOI: 10.14218/JCTH.2015.00025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
279 Yu MW, Yang YC, Yang SY, Chang HC, Liaw YF, Lin SM, Liu CJ, Lee SD, Lin CL, Chen PJ. Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women. Hepatology. 2002;36:156-163. [PMID: 12085360 DOI: 10.1053/jhep.2002.33897] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
280 Péneau C, Zucman-Rossi J, Nault JC. Genomics of Viral Hepatitis-Associated Liver Tumors. J Clin Med 2021;10:1827. [PMID: 33922394 DOI: 10.3390/jcm10091827] [Reference Citation Analysis]
281 Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis. Oncogene. 2000;19:5054-5062. [PMID: 11042693 DOI: 10.1038/sj.onc.1203885] [Cited by in Crossref: 108] [Cited by in F6Publishing: 107] [Article Influence: 5.1] [Reference Citation Analysis]
282 Feitelson MA. c-myc overexpression in hepatocarcinogenesis. Human Pathology 2004;35:1299-302. [DOI: 10.1016/j.humpath.2004.09.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
283 Kim SJ, Syed GH, Siddiqui A. Hepatitis C virus induces the mitochondrial translocation of Parkin and subsequent mitophagy. PLoS Pathog. 2013;9:e1003285. [PMID: 23555273 DOI: 10.1371/journal.ppat.1003285] [Cited by in Crossref: 117] [Cited by in F6Publishing: 113] [Article Influence: 14.6] [Reference Citation Analysis]
284 McGivern DR, Lemon SM. Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene. 2011;30:1969-1983. [PMID: 21258404 DOI: 10.1038/onc.2010.594] [Cited by in Crossref: 136] [Cited by in F6Publishing: 130] [Article Influence: 13.6] [Reference Citation Analysis]
285 Iqbal J, McRae S, Banaudha K, Mai T, Waris G. Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes. J Biol Chem 2013;288:36994-7009. [PMID: 24240095 DOI: 10.1074/jbc.M113.492314] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
286 Kawamura Y, Arase Y, Ikeda K, Hirakawa M, Hosaka T, Kobayashi M, Saitoh S, Yatsuji H, Sezaki H, Akuta N. Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients. Am J Med. 2010;123:951-956.e1. [PMID: 20920698 DOI: 10.1016/j.amjmed.2010.05.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
287 Kanda T, Goto T, Hirotsu Y, Moriyama M, Omata M. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review. Int J Mol Sci. 2019;20. [PMID: 30889843 DOI: 10.3390/ijms] [Cited by in Crossref: 22] [Cited by in F6Publishing: 2] [Article Influence: 11.0] [Reference Citation Analysis]
288 Puri P, Sanyal AJ. Role of Obesity, Insulin Resistance, and Steatosis in Hepatitis C Virus Infection. Clinics in Liver Disease 2006;10:793-819. [DOI: 10.1016/j.cld.2006.08.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
289 Sabile A, Perlemuter G, Bono F, Kohara K, Demaugre F, Kohara M, Matsuura Y, Miyamura T, Bréchot C, Barba G. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology. 1999;30:1064-1076. [PMID: 10498661 DOI: 10.1002/hep.510300429] [Cited by in Crossref: 134] [Cited by in F6Publishing: 126] [Article Influence: 6.1] [Reference Citation Analysis]
290 Saitou K, Mizumoto K, Nishimura T, Kai C, Tsukiyama-kohara K. Hepatitis C virus-core protein facilitates the degradation of Ku70 and reduces DNA-PK activity in hepatocytes. Virus Research 2009;144:266-71. [DOI: 10.1016/j.virusres.2009.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
291 Knobler H, Malnick S. Hepatitis C and insulin action: An intimate relationship. World J Hepatol 2016;8:131-8. [PMID: 26807209 DOI: 10.4254/wjh.v8.i2.131] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
292 Hussein MR. Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt. Liver Int 2004;24:552-60. [PMID: 15566504 DOI: 10.1111/j.1478-3231.2004.0962.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
293 Hino K, Nishina S, Sasaki K, Hara Y. Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection. Free Radic Biol Med 2019;133:193-9. [PMID: 30268888 DOI: 10.1016/j.freeradbiomed.2018.09.044] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
294 Colombo M. Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma. Journal of Hepatology 1999;31:25-30. [DOI: 10.1016/s0168-8278(99)80370-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
295 Alekseeva E, Sominskaya I, Skrastina D, Egorova I, Starodubova E, Kushners E, Mihailova M, Petrakova N, Bruvere R, Kozlovskaya T. Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen. Genet Vaccines Ther. 2009;7:7. [PMID: 19505299 DOI: 10.1186/1479-0556-7-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
296 Shyu P Jr, Wong XFA, Crasta K, Thibault G. Dropping in on lipid droplets: insights into cellular stress and cancer.Biosci Rep. 2018;38. [PMID: 30111611 DOI: 10.1042/BSR20180764] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
297 Wakita T, Katsume A, Kato J, Taya C, Yonekawa H, Kanegae Y, Saito I, Hayashi Y, Koike M, Miyamoto M, Hiasa Y, Kohara M. Possible role of cytotoxic T cells in acute liver injury in hepatitis C virus cDNA transgenic mice mediated by Cre/loxP system. J Med Virol 2000;62:308-17. [PMID: 11055240 DOI: 10.1002/1096-9071(200011)62:3<308::aid-jmv2>3.0.co;2-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
298 Michielsen PP, Francque SM, van Dongen JL. Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol. 2005;3:27. [PMID: 15907199 DOI: 10.1186/1477-7819-3-27] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 5.3] [Reference Citation Analysis]
299 Kim GW, Lee SH, Cho H, Kim M, Shin EC, Oh JW. Hepatitis C Virus Core Protein Promotes miR-122 Destabilization by Inhibiting GLD-2. PLoS Pathog 2016;12:e1005714. [PMID: 27366906 DOI: 10.1371/journal.ppat.1005714] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
300 Tsukiyama-Kohara K. Role of oxidative stress in hepatocarcinogenesis induced by hepatitis C virus. Int J Mol Sci. 2012;13:15271-15278. [PMID: 23203124 DOI: 10.3390/ijms131115271] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
301 Maryam M, Idrees M. Study of promoter hypomethylation profiles of RAS oncogenes in hepatocellular carcinoma derived from hepatitis C virus genotype 3a in Pakistani population: MARYAM and IDREES. J Med Virol 2018;90:1516-23. [DOI: 10.1002/jmv.25221] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
302 Mueller S, Millonig G, Seitz HK. Alcoholic liver disease and hepatitis C: a frequently underestimated combination. World J Gastroenterol 2009;15:3462-71. [PMID: 19630099 DOI: 10.3748/wjg.15.3462] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
303 Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, Okuda M, Gosert R, Xiao SY, Weinman SA. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology. 2002;122:352-365. [PMID: 11832450 DOI: 10.1053/gast.2002.31001] [Cited by in Crossref: 337] [Cited by in F6Publishing: 324] [Article Influence: 17.7] [Reference Citation Analysis]
304 Furutani T, Hino K, Okuda M, Gondo T, Nishina S, Kitase A, Korenaga M, Xiao SY, Weinman SA, Lemon SM. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology. 2006;130:2087-2098. [PMID: 16762631 DOI: 10.1053/j.gastro.2006.02.060] [Cited by in Crossref: 118] [Cited by in F6Publishing: 107] [Article Influence: 7.9] [Reference Citation Analysis]
305 Dumoulin FL, vsn dem Bussche A, Söhne J, Sauerbruch T, Spengler U. Hepatitis C virus core protein does not inhibit apoptosis in human hepatoma cells. Eur J Clin Invest. 1999;29:940-946. [PMID: 10583438 DOI: 10.1046/j.1365-2362.1999.00559.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
306 Koutb F, Abdel-Rahman S, Hassona E, Haggag A. Association of C-myc and p53 Gene Expression and Polymorphisms with Hepatitis C (HCV) Chronic Infection, Cirrhosis and Hepatocellular Carcinoma (HCC) Stages in Egypt. Asian Pac J Cancer Prev 2017;18:2049-57. [PMID: 28843220 DOI: 10.22034/APJCP.2017.18.8.2049] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
307 Lee H, Woo Y, Kim SS, Kim S, Park B, Choi D, Jang KL. Hepatitis C virus Core protein overcomes all-trans retinoic acid-induced cell growth arrest by inhibiting retinoic acid receptor-β2 expression via DNA methylation. Cancer Letters 2013;335:372-9. [DOI: 10.1016/j.canlet.2013.02.057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
308 McGivern DR, Lemon SM. Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer. Annu Rev Pathol. 2009;4:399-415. [PMID: 18928409 DOI: 10.1146/annurev.pathol.4.110807.092202] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 5.8] [Reference Citation Analysis]
309 Robinson MK, Weiner LM, Adams GP. Improving mono-clonal antibodies for cancer therapy. Drug Development Res. 2004;61:172-187. [PMID: 11819809 DOI: 10.1002/ddr.10345] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
310 Liu Y, Wang X, Li S, Hu H, Zhang D, Hu P, Yang Y, Ren H. The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: A quantitative proteomic based study. J Proteomics. 2014;106:99-112. [PMID: 24769235 DOI: 10.1016/j.jprot.2014.04.021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
311 Kasai H, Mochizuki K, Tanaka T, Yamashita A, Matsuura Y, Moriishi K. Induction of HOX Genes by Hepatitis C Virus Infection via Impairment of Histone H2A Monoubiquitination. J Virol 2021;95:e01784-20. [PMID: 33328315 DOI: 10.1128/JVI.01784-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
312 Yoon SK, Park YM, Byun BH, Bae SH, Yang JM, Ahn BM, Lee YS, Lee CD, Sun HS, Kim BS. The relationship between virological characteristics of hepatitis C virus (HCV) and reactivity to the regional specific proteins of HCV. Korean J Intern Med 2000;15:109-16. [PMID: 10992722 DOI: 10.3904/kjim.2000.15.2.109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
313 Lemon SM, McGivern DR. Is hepatitis C virus carcinogenic? Gastroenterology. 2012;142:1274-1278. [PMID: 22537433 DOI: 10.1053/j.gastro.2012.01.045] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
314 Li HC, Ma HC, Yang CH, Lo SY. Production and pathogenicity of hepatitis C virus core gene products. World J Gastroenterol. 2014;20:7104-7122. [PMID: 24966583 DOI: 10.3748/wjg.v20.i23.7104] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
315 Kew MC. The role of cirrhosis in the etiology of hepatocellular carcinoma. J Gastrointest Cancer. 2014;45:12-21. [PMID: 24203525 DOI: 10.1007/s12029-013-9556-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
316 Miyazawa T. Lipid hydroperoxides in nutrition, health, and diseases. Proc Jpn Acad Ser B Phys Biol Sci 2021;97:161-96. [PMID: 33840675 DOI: 10.2183/pjab.97.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
317 Leenders MW, Nijkamp MW, Borel Rinkes IH. Mouse models in liver cancer research: a review of current literature. World J Gastroenterol. 2008;14:6915-6923. [PMID: 19058325 DOI: 10.3748/wjg.14.6915] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
318 Matsumura H, Nirei K, Nakamura H, Higuchi T, Arakawa Y, Ogawa M, Tanaka N, Moriyama M. Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors. World J Gastroenterol. 2013;19:4887-4896. [PMID: 23946593 DOI: 10.3748/wjg.v19.i30.4887] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
319 Guntaka RV, Padala MK. Interaction of Hepatitis C Viral Proteins with Cellular Oncoproteins in the Induction of Liver Cancer. ISRN Virology 2014;2014:1-11. [DOI: 10.1155/2014/351407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
320 Yutani S, Komatsu N, Shichijo S, Yoshida K, Takedatsu H, Itou M, Kuromatu R, Ide T, Tanaka M, Sata M, Yamada A, Itoh K. Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles. Cancer Science 2009;100:1935-42. [DOI: 10.1111/j.1349-7006.2009.01256.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
321 Shimizu I. Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. J Gastroenterol Hepatol. 2000;15 Suppl:D84-D90. [PMID: 10759225 DOI: 10.1046/j.1440-1746.2000.02138.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 72] [Article Influence: 4.4] [Reference Citation Analysis]
322 Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol. 2008;14:4300-4308. [PMID: 18666317 DOI: 10.3748/wjg.14.4300] [Cited by in CrossRef: 398] [Cited by in F6Publishing: 362] [Article Influence: 30.6] [Reference Citation Analysis]
323 Penin F. Structural biology of hepatitis C virus. Clin Liver Dis. 2003;7:1-21, vii. [PMID: 12691456 DOI: 10.1016/s1089-3261(02)00066-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
324 Li Y, Shi X, Zhang J, Zhang X, Martin RC. Hepatic protection and anticancer activity of curcuma: a potential chemopreventive strategy against hepatocellular carcinoma. Int J Oncol 2014;44:505-13. [PMID: 24270742 DOI: 10.3892/ijo.2013.2184] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
325 Koshiyama A, Ichibangase T, Imai K. Fluorogenic Derivatization Followed by HPLC Quantification and Final Identification of Proteins by HPLC-Tandem Mass Spectrometry (FD-LC-MS/MS) Method. In: Li S, editor. Quantitative Proteome Analysis. Pan Stanford Publishing; 2013. pp. 1-16. [DOI: 10.1201/b15298-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
326 Fishman SL, Factor SH, Balestrieri C, Fan X, Dibisceglie AM, Desai SM, Benson G, Branch AD. Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma. Clin Cancer Res 2009;15:3205-13. [PMID: 19383824 DOI: 10.1158/1078-0432.CCR-08-2418] [Cited by in Crossref: 57] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
327 Ma Z, Shen QH, Chen GM, Zhang DZ. Biological impact of hepatitis B virus X-hepatitis C virus core fusion gene on human hepatocytes. World J Gastroenterol 2008;14:5412-8. [PMID: 18803352 DOI: 10.3748/wjg.14.5412] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
328 Jiang XH, Xie YT, Cai YP, Ren J, Ma T. Effects of hepatitis C virus core protein and nonstructural protein 4B on the Wnt/β-catenin pathway. BMC Microbiol 2017;17:124. [PMID: 28545480 DOI: 10.1186/s12866-017-1032-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
329 Dubourdeau M, Miyamura T, Matsuura Y, Alric L, Pipy B, Rousseau D. Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21WAF1 down-regulation – effect of transforming growth factor β. Journal of Hepatology 2002;37:486-92. [DOI: 10.1016/s0168-8278(02)00241-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
330 Asselah T, Boyer N, Guimont MC, Cazals-Hatem D, Tubach F, Nahon K, Daïkha H, Vidaud D, Martinot M, Vidaud M, Degott C, Valla D, Marcellin P. Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C. Gut 2003;52:1638-43. [PMID: 14570735 DOI: 10.1136/gut.52.11.1638] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 4.7] [Reference Citation Analysis]
331 Cuninghame S, Jackson R, Zehbe I. Hypoxia-inducible factor 1 and its role in viral carcinogenesis. Virology. 2014;456-457:370-383. [PMID: 24698149 DOI: 10.1016/j.virol.2014.02.027] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
332 Shiu TY, Huang SM, Shih YL, Chu HC, Chang WK, Hsieh TY. Hepatitis C virus core protein down-regulates p21(Waf1/Cip1) and inhibits curcumin-induced apoptosis through microRNA-345 targeting in human hepatoma cells. PLoS One. 2013;8:e61089. [PMID: 23577194 DOI: 10.1371/journal.pone.0061089] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
333 Moinzadeh P, Breuhahn K, Stützer H, Schirmacher P. Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade--results of an explorative CGH meta-analysis. Br J Cancer. 2005;92:935-941. [PMID: 15756261 DOI: 10.1038/sj.bjc.6602448] [Cited by in Crossref: 110] [Cited by in F6Publishing: 103] [Article Influence: 6.9] [Reference Citation Analysis]
334 Shimizu K, Soroida Y, Sato M, Hikita H, Kobayashi T, Endo M, Sato M, Gotoh H, Iwai T, Tateishi R, Koike K, Yatomi Y, Ikeda H. Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter. Sci Rep 2018;8:7845. [PMID: 29777191 DOI: 10.1038/s41598-018-26293-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
335 Jahan S, Ashfaq UA, Qasim M, Khaliq S, Saleem MJ, Afzal N. Hepatitis C virus to hepatocellular carcinoma. Infect Agent Cancer. 2012;7:2. [PMID: 22289144 DOI: 10.1186/1750-9378-7-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
336 Mukaide M, Sugiyama M, Korenaga M, Murata K, Kanto T, Masaki N, Mizokami M. High-throughput and sensitive next-generation droplet digital PCR assay for the quantitation of the hepatitis C virus mutation at core amino acid 70. J Virol Methods. 2014;207:169-177. [PMID: 25019167 DOI: 10.1016/j.jviromet.2014.07.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
337 Del Campo JA, Romero-Gómez M. Steatosis and insulin resistance in hepatitis C: a way out for the virus? World J Gastroenterol 2009;15:5014-9. [PMID: 19859993 DOI: 10.3748/wjg.15.5014] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
338 Hervé S, Riachi G, Noblet C, Guillement N, Tanasescu S, Goria O, Thuillez C, Tranvouez JL, Ducrotte P, Lerebours E. Acute hepatitis due to buprenorphine administration. Eur J Gastroenterol Hepatol 2004;16:1033-7. [PMID: 15371928 DOI: 10.1097/00042737-200410000-00013] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
339 Koike K. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways. J Gastroenterol Hepatol. 2007;22 Suppl 1:S108-S111. [PMID: 17567457 DOI: 10.1111/j.1440-1746.2006.04669.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 5.6] [Reference Citation Analysis]
340 Takuma Y, Nouso K, Makino Y, Saito S, Takayama H, Takahara M, Takahashi H, Murakami I, Takeuchi H. Hepatic steatosis correlates with the postoperative recurrence of hepatitis C virus-associated hepatocellular carcinoma. Liver Int. 2007;27:620-626. [PMID: 17498246 DOI: 10.1111/j.1478-3231.2007.01462.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
341 Blonski W, Reddy KR. Hepatitis C Virus Infection and Hepatocellular Carcinoma. Clinics in Liver Disease 2008;12:661-74. [DOI: 10.1016/j.cld.2008.03.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
342 Hosui A, Takehara T, Ohkawa K, Kanazawa Y, Tatsumi T, Yamaguchi S, Sakamori R, Hiramatsu N, Kanto T, Hayashi N. Suppressive effect on hepatocyte differentiation of hepatitis C virus core protein. Biochem Biophys Res Commun. 2006;346:1125-1130. [PMID: 16806084 DOI: 10.1016/j.bbrc.2006.05.114] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
343 Edamoto Y, Hara A, Biernat W, Terracciano L, Cathomas G, Riehle HM, Matsuda M, Fujii H, Scoazec JY, Ohgaki H. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int J Cancer. 2003;106:334-341. [PMID: 12845670 DOI: 10.1002/ijc.11254] [Cited by in Crossref: 155] [Cited by in F6Publishing: 139] [Article Influence: 8.6] [Reference Citation Analysis]
344 Bodzin AS, Busuttil RW. Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome. World J Hepatol. 2015;7:1157-1167. [PMID: 26019732 DOI: 10.4254/wjh.v7.i9.1157] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 8.2] [Reference Citation Analysis]
345 Honda T. Links between Human LINE-1 Retrotransposons and Hepatitis Virus-Related Hepatocellular Carcinoma. Front Chem 2016;4:21. [PMID: 27242996 DOI: 10.3389/fchem.2016.00021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
346 Wei W, Li B, Hanes MA, Kakar S, Chen X, Liu L. S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis. Sci Transl Med 2010;2:19ra13. [PMID: 20371487 DOI: 10.1126/scitranslmed.3000328] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 7.1] [Reference Citation Analysis]
347 Kumthip K, Maneekarn N. The role of HCV proteins on treatment outcomes. Virol J 2015;12:217. [PMID: 26666318 DOI: 10.1186/s12985-015-0450-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
348 Watashi K, Shimotohno K. The roles of hepatitis C virus proteins in modulation of cellular functions: A novel action mechanism of the HCV core protein on gene regulation by nuclear hormone receptors. Cancer Science 2003;94:937-43. [DOI: 10.1111/j.1349-7006.2003.tb01381.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
349 Nakamoto S, Imazeki F, Fukai K, Fujiwara K, Arai M, Kanda T, Yonemitsu Y, Yokosuka O. Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development. J Hepatol. 2010;52:72-78. [PMID: 19910070 DOI: 10.1016/j.jhep.2009.10.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
350 Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, Hamamura K, Imai Y, Yoshida H, Shiina S. Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion. Hepatology. 2000;32:1216-1223. [PMID: 11093727 DOI: 10.1053/jhep.2000.20237] [Cited by in Crossref: 94] [Cited by in F6Publishing: 85] [Article Influence: 4.7] [Reference Citation Analysis]
351 Tsutsumi T, Suzuki T, Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Matsuura Y, Kimura S, Koike K, Miyamura T. Alteration of intrahepatic cytokine expression and AP-1 activation in transgenic mice expressing hepatitis C virus core protein. Virology. 2002;304:415-424. [PMID: 12504580 DOI: 10.1006/viro.2002.1702] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 3.7] [Reference Citation Analysis]
352 Debes JD, de Knegt RJ, Boonstra A. The Path to Cancer and Back: Immune Modulation During Hepatitis C Virus Infection, Progression to Fibrosis and Cancer, and Unexpected Roles of New Antivirals. Transplantation. 2017;101:910-915. [PMID: 28045877 DOI: 10.1097/tp.0000000000001623] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
353 Tang ZY. Hepatocellular carcinoma--cause, treatment and metastasis. World J Gastroenterol. 2001;7:445-454. [PMID: 11819809 DOI: 10.3748/wjg.v7.i4.445] [Cited by in CrossRef: 275] [Cited by in F6Publishing: 258] [Article Influence: 14.5] [Reference Citation Analysis]
354 Roingeard P, Hourioux C. Hepatitis C virus core protein, lipid droplets and steatosis. J Viral Hepat. 2008;15:157-164. [PMID: 18086178 DOI: 10.1111/j.1365-2893.2007.00953.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
355 Yu MW, Chang HC, Chang SC, Liaw YF, Lin SM, Liu CJ, Lee SD, Lin CL, Chen PJ, Lin SC. Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk. Hepatology. 2003;38:1393-1400. [PMID: 14647050 DOI: 10.1016/j.hep.2003.09.041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 48] [Article Influence: 0.8] [Reference Citation Analysis]
356 Bility MT, Li F, Cheng L, Su L. Liver immune-pathogenesis and therapy of human liver tropic virus infection in humanized mouse models. J Gastroenterol Hepatol 2013;28 Suppl 1:120-4. [PMID: 23855307 DOI: 10.1111/jgh.12092] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
357 Burm R, Collignon L, Mesalam AA, Meuleman P. Animal Models to Study Hepatitis C Virus Infection. Front Immunol 2018;9:1032. [PMID: 29867998 DOI: 10.3389/fimmu.2018.01032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
358 Ke PY, Chen SS. Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseases. World J Gastroenterol 2014;20:5773-93. [PMID: 24914338 DOI: 10.3748/wjg.v20.i19.5773] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
359 Shirvani-Dastgerdi E, Schwartz RE, Ploss A. Hepatocarcinogenesis associated with hepatitis B, delta and C viruses. Curr Opin Virol 2016;20:1-10. [PMID: 27504999 DOI: 10.1016/j.coviro.2016.07.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
360 Suzuki R, Sakamoto S, Tsutsumi T, Rikimaru A, Tanaka K, Shimoike T, Moriishi K, Iwasaki T, Mizumoto K, Matsuura Y. Molecular determinants for subcellular localization of hepatitis C virus core protein. J Virol. 2005;79:1271-1281. [PMID: 15613354 DOI: 10.1128/jvi.79.2.1271-1281.2005] [Cited by in Crossref: 101] [Cited by in F6Publishing: 55] [Article Influence: 6.3] [Reference Citation Analysis]
361 Hayashi J, Aoki H, Kajino K, Moriyama M, Arakawa Y, Hino O. Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha. Hepatology. 2000;32:958-961. [PMID: 11050045 DOI: 10.1053/jhep.2000.19343] [Cited by in Crossref: 107] [Cited by in F6Publishing: 87] [Article Influence: 5.1] [Reference Citation Analysis]
362 Lee C. Interaction of hepatitis C virus core protein with janus kinase is required for efficient production of infectious viruses. Biomol Ther (Seoul) 2013;21:97-106. [PMID: 24009866 DOI: 10.4062/biomolther.2013.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
363 Yanagitani A, Yamada S, Yasui S, Shimomura T, Murai R, Murawaki Y, Hashiguchi K, Kanbe T, Saeki T, Ichiba M, Tanabe Y, Yoshida Y, Morino S, Kurimasa A, Usuda N, Yamazaki H, Kunisada T, Ito H, Murawaki Y, Shiota G. Retinoic acid receptor alpha dominant negative form causes steatohepatitis and liver tumors in transgenic mice. Hepatology 2004;40:366-75. [PMID: 15368441 DOI: 10.1002/hep.20335] [Cited by in Crossref: 98] [Cited by in F6Publishing: 82] [Article Influence: 5.8] [Reference Citation Analysis]
364 Kawaguchi T, Yoshida T, Harada M, Hisamoto T, Nagao Y, Ide T, Taniguchi E, Kumemura H, Hanada S, Maeyama M, Baba S, Koga H, Kumashiro R, Ueno T, Ogata H, Yoshimura A, Sata M. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol. 2004;165:1499-1508. [PMID: 15509521 DOI: 10.1016/s0002-9440(10)63408-6] [Cited by in Crossref: 382] [Cited by in F6Publishing: 173] [Article Influence: 22.5] [Reference Citation Analysis]
365 Pol S, Vallet-Pichard A, Hermine O. Extrahepatic cancers and chronic HCV infection. Nat Rev Gastroenterol Hepatol. 2018;15:283-290. [PMID: 29339810 DOI: 10.1038/nrgastro.2017.172] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 10.3] [Reference Citation Analysis]
366 Machida K. Tumor-initiating stem-like cells and drug resistance: carcinogenesis through Toll-like receptors, environmental factors, and virus. Drug Deliv Transl Res 2013;3:152-64. [PMID: 25787983 DOI: 10.1007/s13346-012-0115-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
367 El-Shamy A, Eng FJ, Doyle EH, Klepper AL, Sun X, Sangiovanni A, Iavarone M, Colombo M, Schwartz RE, Hoshida Y, Branch AD. A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene. J Hepatol 2015;63:1323-33. [PMID: 26220749 DOI: 10.1016/j.jhep.2015.07.024] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
368 Krekulová L, Rehák V, Riley LW. Structure and functions of hepatitis C virus proteins: 15 years after. Folia Microbiol (Praha) 2006;51:665-80. [PMID: 17455808 DOI: 10.1007/BF02931636] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
369 Falcón V, Acosta-Rivero N, Chinea G, de la Rosa MC, Menéndez I, Dueñas-Carrera S, Gra B, Rodriguez A, Tsutsumi V, Shibayama M, Luna-Munoz J, Miranda-Sanchez MM, Morales-Grillo J, Kouri J. Nuclear localization of nucleocapsid-like particles and HCV core protein in hepatocytes of a chronically HCV-infected patient. Biochem Biophys Res Commun 2003;310:54-8. [PMID: 14511647 DOI: 10.1016/j.bbrc.2003.08.118] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
370 Wu JM, Skill NJ, Maluccio MA. Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma. HPB (Oxford). 2010;12:625-636. [PMID: 20961371 DOI: 10.1111/j.1477-2574.2010.00207.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
371 Shimizu I, Kohno N, Tamaki K, Shono M, Huang HW, He JH, Yao DF. Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. World J Gastroenterol. 2007;13:4295-4305. [PMID: 17708600 DOI: 10.3748/wjg.v13.i32.4295] [Cited by in CrossRef: 95] [Cited by in F6Publishing: 83] [Article Influence: 6.8] [Reference Citation Analysis]
372 Sugiyama K, Ebinuma H, Nakamoto N, Sakasegawa N, Murakami Y, Chu PS, Usui S, Ishibashi Y, Wakayama Y, Taniki N. Prominent steatosis with hypermetabolism of the cell line permissive for years of infection with hepatitis C virus. PLoS One. 2014;9:e94460. [PMID: 24718268 DOI: 10.1371/journal.pone.0094460] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
373 Machida K, Tsukamoto H, Liu JC, Han YP, Govindarajan S, Lai MM, Akira S, Ou JH. c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair. Hepatology. 2010;52:480-492. [PMID: 20683948 DOI: 10.1002/hep.23697] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 5.9] [Reference Citation Analysis]
374 Shimizu I, Inoue H, Yano M, Shinomiya H, Wada S, Tsuji Y, Tsutsui A, Okamura S, Shibata H, Ito S. Estrogen receptor levels and lipid peroxidation in hepatocellular carcinoma with hepatitis C virus infection. Liver 2001;21:342-9. [PMID: 11589771 DOI: 10.1034/j.1600-0676.2001.210507.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
375 Seko Y, Akuta N, Suzuki F, Kawamura Y, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Saitoh S. Amino acid substitutions in the hepatitis C Virus core region and lipid metabolism are associated with hepatocarcinogenesis in nonresponders to interferon plus ribavirin combination therapy. Intervirology. 2013;56:13-21. [PMID: 22907167 DOI: 10.1159/000339993] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
376 Tada S, Saito H, Ebinuma H, Ojiro K, Yamagishi Y, Kumagai N, Inagaki Y, Masuda T, Nishida J, Takahashi M. Treatment of hepatitis C virus with peg-interferon and ribavirin combination therapy significantly affects lipid metabolism. Hepatol Res. 2009;39:195-199. [PMID: 19054155 DOI: 10.1111/j.1872-034x.2008.00439.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
377 Tanaka H, Fujita N, Sugimoto R, Urawa N, Horiike S, Kobayashi Y, Iwasa M, Ma N, Kawanishi S, Watanabe S, Kaito M, Takei Y. Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C. Br J Cancer 2008;98:580-6. [PMID: 18231107 DOI: 10.1038/sj.bjc.6604204] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 6.3] [Reference Citation Analysis]
378 Qiang G, Jhaveri R. Lipid droplet binding of hepatitis C virus core protein genotype 3. ISRN Gastroenterol 2012;2012:176728. [PMID: 22844606 DOI: 10.5402/2012/176728] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
379 Miura M, Maekawa S, Takano S, Komatsu N, Tatsumi A, Asakawa Y, Shindo K, Amemiya F, Nakayama Y, Inoue T. Deep-sequencing analysis of the association between the quasispecies nature of the hepatitis C virus core region and disease progression. J Virol. 2013;87:12541-12551. [PMID: 23946458 DOI: 10.1128/jvi.00826-13] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
380 Schreiner S, Wodrich H. Virion factors that target Daxx to overcome intrinsic immunity. J Virol 2013;87:10412-22. [PMID: 23864634 DOI: 10.1128/JVI.00425-13] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
381 Chang ML, Chen JC, Yeh CT, Sheen IS, Tai DI, Chang MY, Chiu CT, Lin DY, Bissell DM. Topological and evolutional relationships between HCV core protein and hepatic lipid vesicles: studies in vitro and in conditionally transgenic mice. World J Gastroenterol. 2007;13:3472-3477. [PMID: 17659694 DOI: 10.3748/wjg.v13.i25.3472] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
382 Rabe C, Pilz T, Klostermann C, Berna M, Schild HH, Sauerbruch T, Caselmann WH. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol 2001;7:208-15. [PMID: 11819762 DOI: 10.3748/wjg.v7.i2.208] [Cited by in CrossRef: 76] [Cited by in F6Publishing: 67] [Article Influence: 4.0] [Reference Citation Analysis]
383 Zhou JJ, Chen RF, Deng XG, Zhou Y, Ye X, Yu M, Tang J, He XY, Cheng D, Zeng B. Hepatitis C virus core protein regulates NANOG expression via the stat3 pathway. FEBS Lett. 2014;588:566-573. [PMID: 24462277 DOI: 10.1016/j.febslet.2013.11.041] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
384 Tai DI, Tsai SL, Chen YM, Chuang YL, Peng CY, Sheen IS, Yeh CT, Chang KS, Huang SN, Kuo GC. Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology. 2000;31:656-664. [PMID: 10706556 DOI: 10.1002/hep.510310316] [Cited by in Crossref: 141] [Cited by in F6Publishing: 131] [Article Influence: 6.7] [Reference Citation Analysis]
385 Ogata F, Akuta N, Kobayashi M, Fujiyama S, Kawamura Y, Sezaki H, Hosaka T, Kobayashi M, Saitoh S, Suzuki Y, Suzuki F, Arase Y, Ikeda K, Kumada H. Amino acid substitutions in the hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by all-oral direct-acting antiviral regimens. J Med Virol 2018;90:1087-93. [PMID: 29427443 DOI: 10.1002/jmv.25047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
386 Jung EY, Lee MN, Yang HY, Yu D, Jang KL. The repressive activity of hepatitis C virus core protein on the transcription of p21(waf1) is regulated by protein kinase A-mediated phosphorylation. Virus Res. 2001;79:109-115. [PMID: 11551651 DOI: 10.1016/S0168-1702(01)00335-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
387 Cavallari I, Scattolin G, Silic-Benussi M, Raimondi V, D'Agostino DM, Ciminale V. Mitochondrial Proteins Coded by Human Tumor Viruses. Front Microbiol 2018;9:81. [PMID: 29467726 DOI: 10.3389/fmicb.2018.00081] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
388 Koike K, Tsutsumi T, Miyoshi H, Shinzawa S, Shintani Y, Fujie H, Yotsuyanagi H, Moriya K. Molecular basis for the synergy between alcohol and hepatitis C virus in hepatocarcinogenesis. J Gastroenterol Hepatol. 2008;23 Suppl 1:S87-S91. [PMID: 18336672 DOI: 10.1111/j.1440-1746.2007.05292.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
389 Nakagawa H, Maeda S, Yoshida H, Tateishi R, Masuzaki R, Ohki T, Hayakawa Y, Kinoshita H, Yamakado M, Kato N. Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. Int J Cancer. 2009;125:2264-2269. [PMID: 19585572 DOI: 10.1002/ijc.24720] [Cited by in Crossref: 114] [Cited by in F6Publishing: 108] [Article Influence: 9.5] [Reference Citation Analysis]
390 Chen Y, Wang X, Wang J, Yan Z, Luo J. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer. 2012;48:2137-2145. [PMID: 22446023 DOI: 10.1016/j.ejca.2012.02.063] [Cited by in Crossref: 126] [Cited by in F6Publishing: 109] [Article Influence: 14.0] [Reference Citation Analysis]
391 Ferreira AR, Ramos B, Nunes A, Ribeiro D. Hepatitis C Virus: Evading the Intracellular Innate Immunity. J Clin Med 2020;9:E790. [PMID: 32183176 DOI: 10.3390/jcm9030790] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
392 Kern MA, Breuhahn K, Schuchmann M, Schirmacher P. [Molecular pathogenesis of hepatocellular carcinoma: new therapeutic approaches and predictive pathology]. Pathologe 2007;28:261-8. [PMID: 17605064 DOI: 10.1007/s00292-007-0890-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
393 Uraki S, Tameda M, Sugimoto K, Shiraki K, Takei Y, Nobori T, Ito M. Substitution in Amino Acid 70 of Hepatitis C Virus Core Protein Changes the Adipokine Profile via Toll-Like Receptor 2/4 Signaling. PLoS One 2015;10:e0131346. [PMID: 26121241 DOI: 10.1371/journal.pone.0131346] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
394 Vitaglione P, Morisco F, Caporaso N, Fogliano V. Dietary antioxidant compounds and liver health. Crit Rev Food Sci Nutr. 2004;44:575-586. [PMID: 15969329 DOI: 10.1080/10408690490911701] [Cited by in Crossref: 181] [Cited by in F6Publishing: 156] [Article Influence: 11.3] [Reference Citation Analysis]
395 Bailey MA, Brunt EM. Hepatocellular carcinoma: predisposing conditions and precursor lesions. Hematology/Oncology Clinics of North America 2003;17:625-46. [DOI: 10.1016/s0889-8588(03)00018-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
396 Duong FH, Dill MT, Matter MS, Makowska Z, Calabrese D, Dietsche T, Ketterer S, Terracciano L, Heim MH. Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53. Carcinogenesis 2014;35:114-22. [PMID: 23901063 DOI: 10.1093/carcin/bgt258] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
397 Tsai TY, Wang WT, Li HK, Chen WJ, Tsai YH, Chao CH, Wu Lee YH. RNA helicase DDX3 maintains lipid homeostasis through upregulation of the microsomal triglyceride transfer protein by interacting with HNF4 and SHP. Sci Rep 2017;7:41452. [PMID: 28128295 DOI: 10.1038/srep41452] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
398 Mengshol JA, Golden-mason L, Rosen HR. Mechanisms of Disease: HCV-induced liver injury. Nat Rev Gastroenterol Hepatol 2007;4:622-34. [DOI: 10.1038/ncpgasthep0961] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 5.1] [Reference Citation Analysis]
399 Klein KC, Dellos SR, Lingappa JR. Identification of residues in the hepatitis C virus core protein that are critical for capsid assembly in a cell-free system. J Virol 2005;79:6814-26. [PMID: 15890921 DOI: 10.1128/JVI.79.11.6814-6826.2005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
400 Depla M, Uzbekov R, Hourioux C, Blanchard E, Le Gouge A, Gillet L, Roingeard P. Ultrastructural and quantitative analysis of the lipid droplet clustering induced by hepatitis C virus core protein. Cell Mol Life Sci. 2010;67:3151-3161. [PMID: 20422251 DOI: 10.1007/s00018-010-0373-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
401 Koike K. Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection. J Gastroenterol. 2009;44 Suppl 19:82-88. [PMID: 19148799 DOI: 10.1007/s00535-008-2276-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
402 Otsuka M, Kato N, Taniguchi H, Yoshida H, Goto T, Shiratori Y, Omata M. Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression. Virology. 2002;296:84-93. [PMID: 12036320 DOI: 10.1006/viro.2002.1371] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
403 White MK, Pagano JS, Khalili K. Viruses and human cancers: a long road of discovery of molecular paradigms. Clin Microbiol Rev. 2014;27:463-481. [PMID: 24982317 DOI: 10.1128/cmr.00124-13] [Cited by in Crossref: 93] [Cited by in F6Publishing: 40] [Article Influence: 15.5] [Reference Citation Analysis]
404 Kremsdorf D, Brezillon N. New animal models for hepatitis C viral infection and pathogenesis studies. World J Gastroenterol 2007;13:2427-35. [PMID: 17552025 DOI: 10.3748/wjg.v13.i17.2427] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
405 Brass V, Moradpour D, Blum HE. Hepatitis C virus infection: in vivo and in vitro models. J Viral Hepat. 2007;14 Suppl 1:64-67. [PMID: 17958645 DOI: 10.1111/j.1365-2893.2007.00918.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
406 Branda M, Wands JR. Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma. Hepatology. 2006;43:891-902. [PMID: 16628664 DOI: 10.1002/hep.21196] [Cited by in Crossref: 77] [Cited by in F6Publishing: 70] [Article Influence: 5.1] [Reference Citation Analysis]
407 Onaga M, Ido A, Hasuike S, Uto H, Moriuchi A, Nagata K, Hori T, Hayash K, Tsubouchi H. Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, L-amino acid-defined diet, accelerates motility of hepatoma cells. J Hepatol. 2003;39:779-785. [PMID: 14568261 DOI: 10.1016/s0168-8278(03)00361-1] [Cited by in Crossref: 66] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
408 Taniguchi H, Kato N, Otsuka M, Goto T, Yoshida H, Shiratori Y, Omata M. Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. J Med Virol. 2004;72:52-59. [PMID: 14635011 DOI: 10.1002/jmv.10545] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 5.4] [Reference Citation Analysis]
409 Aghemo A, Colombo M. Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside. Semin Immunopathol 2013;35:111-20. [DOI: 10.1007/s00281-012-0330-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
410 Dansako H, Naganuma A, Nakamura T, Ikeda F, Nozaki A, Kato N. Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element. Virus Res. 2003;97:17-30. [PMID: 14550584 DOI: 10.1016/S0168-1702(03)00218-1] [Cited by in Crossref: 46] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
411 Panteva M, Korkaya H, Jameel S. Hepatitis viruses and the MAPK pathway: is this a survival strategy? Virus Res. 2003;92:131-140. [PMID: 12686421 DOI: 10.1016/s0168-1702(02)00356-8] [Cited by in Crossref: 53] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
412 Ju H, Han K, Lee JD, Ro SW. Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapy: Transgenic mouse models generated by hydrodynamic transfection. Int J Cancer 2016;138:1601-8. [DOI: 10.1002/ijc.29703] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
413 Okada F, Izutsu R, Goto K, Osaki M. Inflammation-Related Carcinogenesis: Lessons from Animal Models to Clinical Aspects. Cancers (Basel) 2021;13:921. [PMID: 33671768 DOI: 10.3390/cancers13040921] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
414 Mitchell JK, McGivern DR. Mechanisms of hepatocarcinogenesis in chronic hepatitis C. Hepat Oncol 2014;1:293-307. [PMID: 30190964 DOI: 10.2217/hep.14.7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
415 Ma HC, Ku YY, Hsieh YC, Lo SY. Characterization of the cleavage of signal peptide at the C-terminus of hepatitis C virus core protein by signal peptide peptidase. J Biomed Sci. 2007;14:31-41. [PMID: 17237979 DOI: 10.1007/s11373-006-9127-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
416 Kwak J, Tiwari I, Jang KL. Hepatitis C virus core activates proteasomal activator 28γ expression via upregulation of p53 levels to control virus propagation. Journal of General Virology 2017;98:56-67. [DOI: 10.1099/jgv.0.000655] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
417 Hope RG, McLauchlan J. Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein. J Gen Virol. 2000;81:1913-1925. [PMID: 10900028 DOI: 10.1099/0022-1317-81-8-1913] [Cited by in Crossref: 172] [Cited by in F6Publishing: 169] [Article Influence: 8.2] [Reference Citation Analysis]
418 Higgs MR, Lerat H, Pawlotsky JM. Downregulation of Gadd45beta expression by hepatitis C virus leads to defective cell cycle arrest. Cancer Res. 2010;70:4901-4911. [PMID: 20530689 DOI: 10.1158/0008-5472.CAN-09-4554] [Cited by in Crossref: 48] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
419 Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M, Miyazoe S, Ichikawa T, Ishikawa H, Nakao K, Eguchi K. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer. 2003;97:3036-3043. [PMID: 12784339 DOI: 10.1002/cncr.11427] [Cited by in Crossref: 226] [Cited by in F6Publishing: 220] [Article Influence: 12.6] [Reference Citation Analysis]
420 Hayashi T, Tamori A, Nishikawa M, Morikawa H, Enomoto M, Sakaguchi H, Habu D, Kawada N, Kubo S, Nishiguchi S. Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection. Liver Int. 2009;29:126-132. [PMID: 18492017 DOI: 10.1111/j.1478-3231.2008.01772.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
421 Li Y, Tang ZY, Hou JX. Hepatocellular carcinoma: insight from animal models. Nat Rev Gastroenterol Hepatol. 2012;9:32-43. [PMID: 22025031 DOI: 10.1038/nrgastro.2011.196] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 7.9] [Reference Citation Analysis]
422 Sekiguchi T, Kurihara Y, Fukumura J. Phosphorylation of threonine 204 of DEAD-box RNA helicase DDX3 by cyclin B/cdc2 in vitro. Biochem Biophys Res Commun 2007;356:668-73. [PMID: 17379183 DOI: 10.1016/j.bbrc.2007.03.038] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
423 Lake-Bakaar G, Mazzoccoli V, Ruffini L. Digital image analysis of the distribution of proliferating cell nuclear antigen in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dig Dis Sci 2002;47:1644-8. [PMID: 12141830 DOI: 10.1023/a:1015800126283] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
424 Tao J, Ji J, Li X, Ding N, Wu H, Liu Y, Wang XW, Calvisi DF, Song G, Chen X. Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer. Oncotarget 2015;6:6977-88. [PMID: 25762642 DOI: 10.18632/oncotarget.3166] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
425 Fujino T, Nakamuta M, Yada R, Aoyagi Y, Yasutake K, Kohjima M, Fukuizumi K, Yoshimoto T, Harada N, Yada M. Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver. Hepatol Res. 2010;40:923-929. [PMID: 20887597 DOI: 10.1111/j.1872-034x.2010.00700.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
426 Kaplan DE, Reddy KR. Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes. Clin Liver Dis 2003;7:683-714. [PMID: 14509534 DOI: 10.1016/s1089-3261(03)00060-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
427 Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Arase Y. Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha-fetoprotein in patients without hepatocellular carcinoma. J Med Virol. 2008;80:1354-1362. [PMID: 18551609 DOI: 10.1002/jmv.21202] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
428 Savić R, Schuchman EH. Use of Acid Sphingomyelinase for Cancer Therapy. The Role of Sphingolipids in Cancer Development and Therapy. Elsevier; 2013. pp. 91-115. [DOI: 10.1016/b978-0-12-394274-6.00004-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
429 Kamegaya Y, Hiasa Y, Zukerberg L, Fowler N, Blackard JT, Lin W, Choe WH, Schmidt EV, Chung RT. Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis. Hepatology. 2005;41:660-667. [PMID: 15723444 DOI: 10.1002/hep.20621] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
430 Hirano J, Okamoto T, Sugiyama Y, Suzuki T, Kusakabe S, Tokunaga M, Fukuhara T, Sasai M, Tougan T, Matsunaga Y, Yamashita K, Sakai Y, Yamamoto M, Horii T, Standley DM, Moriishi K, Moriya K, Koike K, Matsuura Y. Characterization of SPP inhibitors suppressing propagation of HCV and protozoa. Proc Natl Acad Sci U S A 2017;114:E10782-91. [PMID: 29187532 DOI: 10.1073/pnas.1712484114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
431 Leyssen P, De Clercq E, Neyts J. Perspectives for the Treatment of Infections with Flaviviridae. Clin Microbiol Rev 2000;13:67-82. [DOI: 10.1128/cmr.13.1.67] [Cited by in Crossref: 18] [Cited by in F6Publishing: 33] [Article Influence: 0.9] [Reference Citation Analysis]
432 Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Arase Y, Ikeda K, Kumada H. Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis. Hepatology. 2007;46:1357-1364. [PMID: 17657816 DOI: 10.1002/hep.21836] [Cited by in Crossref: 93] [Cited by in F6Publishing: 87] [Article Influence: 6.6] [Reference Citation Analysis]
433 Kim GJ, Cho SJ, Won NH, Sung JM, Kim H, Chun YH, Park SH. Genomic imbalances in Korean hepatocellular carcinoma. Cancer Genet Cytogenet. 2003;142:129-133. [PMID: 12699889 DOI: 10.1016/s0165-4608(02)00834-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
434 Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Tsukamoto T, Shuto T, Takemura S, Yamamoto T, Ikebe T, Wakasa K. Influence of previous interferon therapy on recurrence after resection of hepatitis c virus-related hepatocellular carcinoma. Jpn J Cancer Res. 2001;92:59-66. [PMID: 11173545 DOI: 10.1111/j.1349-7006.2001.tb01048.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
435 Munakata T, Liang Y, Kim S, McGivern DR, Huibregtse J, Nomoto A, Lemon SM. Hepatitis C virus induces E6AP-dependent degradation of the retinoblastoma protein. PLoS Pathog. 2007;3:1335-1347. [PMID: 17907805 DOI: 10.1371/journal.ppat.0030139] [Cited by in Crossref: 91] [Cited by in F6Publishing: 89] [Article Influence: 6.5] [Reference Citation Analysis]
436 Moradpour D, Blum HE. Pathogenesis of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2005;17:477-483. [PMID: 15827436 DOI: 10.1097/00042737-200505000-00002] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 5.4] [Reference Citation Analysis]
437 Tsuge M, Fujimoto Y, Hiraga N, Zhang Y, Ohnishi M, Kohno T, Abe H, Miki D, Imamura M, Takahashi S. Hepatitis C virus infection suppresses the interferon response in the liver of the human hepatocyte chimeric mouse. PLoS One. 2011;6:e23856. [PMID: 21886832 DOI: 10.1371/journal.pone.0023856] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
438 Yoshida K, Nakamura H, Okuda Y, Enomoto H, Kishima Y, Uyama H, Ito H, Hirasawa T, Inagaki S, Kawase I. Expression of hepatoma-derived growth factor in hepatocarcinogenesis. J Gastroenterol Hepatol. 2003;18:1293-1301. [PMID: 14535987 DOI: 10.1046/j.1440-1746.2003.03191.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
439 Sobesky R, Feray C, Rimlinger F, Derian N, Dos Santos A, Roque-afonso A, Samuel D, Bréchot C, Thiers V. Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection. Hepatology 2007;46:1704-12. [DOI: 10.1002/hep.21898] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
440 Kamei A, Tamaki S, Taniyama H, Takamura S, Nishimura Y, Kagawa Y, Uno-Furuta S, Kaito M, Kim G, Toda M. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by an intrahepatic inoculation with an expression plasmid. Virology. 2000;273:120-126. [PMID: 10891414 DOI: 10.1006/viro.2000.0403] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
441 Hassan M, Ghozlan H, Abdel-Kader O. Activation of RB/E2F signaling pathway is required for the modulation of hepatitis C virus core protein-induced cell growth in liver and non-liver cells. Cell Signal. 2004;16:1375-1385. [PMID: 15381253 DOI: 10.1016/j.cellsig.2004.04.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
442 Akuta N, Suzuki F, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H. Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus. J Med Virol 2009;81:1032-9. [PMID: 19382270 DOI: 10.1002/jmv.21473] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
443 Moriishi K, Shoji I, Mori Y, Suzuki R, Suzuki T, Kataoka C, Matsuura Y. Involvement of PA28gamma in the propagation of hepatitis C virus. Hepatology. 2010;52:411-420. [PMID: 20683941 DOI: 10.1002/hep.23680] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
444 Akuta N, Suzuki F, Sezaki H, Kobayashi M, Fujiyama S, Kawamura Y, Hosaka T, Kobayashi M, Saitoh S, Suzuki Y, Arase Y, Ikeda K, Kumada H. Complex Association of Virus- and Host-Related Factors with Hepatocellular Carcinoma Rate following Hepatitis C Virus Clearance. J Clin Microbiol 2019;57:e01463-18. [PMID: 30381417 DOI: 10.1128/JCM.01463-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
445 Yamaguchi T, Yoshida K, Murata M, Matsuzaki K. Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases. World J Gastroenterol 2014;20:12381-90. [PMID: 25253939 DOI: 10.3748/wjg.v20.i35.12381] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
446 Hassoun Z, Gores GJ. What surgeons should know about viral hepatitis and hepatocellular carcinoma. Surg Oncol Clin N Am. 2003;12:1-11. [PMID: 12735125 DOI: 10.1016/S1055-3207(02)00081-9] [Reference Citation Analysis]
447 Farinati F, Cardin R, Fiorentino M, D’errico A, Grigioni W, Cecchetto A, Naccarato R. Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease: Cytoproliferation and apoptosis in HCV-related hepatitis. Journal of Viral Hepatitis 2001;8:34-40. [DOI: 10.1111/j.1365-2893.2001.00267.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
448 Barth H, Robinet E, Liang TJ, Baumert TF. Mouse models for the study of HCV infection and virus-host interactions. J Hepatol. 2008;49:134-142. [PMID: 18457898 DOI: 10.1016/j.jhep.2008.03.012] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
449 Falcón V, Acosta-Rivero N, Shibayama M, Chinea G, Gavilondo JV, de la Rosa MC, Menéndez I, Gra B, Dueñas-Carrera S, Viña A. HCV core protein localizes in the nuclei of nonparenchymal liver cells from chronically HCV-infected patients. Biochem Biophys Res Commun. 2005;329:1320-1328. [PMID: 15766571 DOI: 10.1016/j.bbrc.2005.02.107] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
450 Abdallah C, Lejamtel C, Benzoubir N, Battaglia S, Sidahmed-Adrar N, Desterke C, Lemasson M, Rosenberg AR, Samuel D, Bréchot C, Pflieger D, Le Naour F, Bourgeade MF. Hepatitis C virus core protein targets 4E-BP1 expression and phosphorylation and potentiates Myc-induced liver carcinogenesis in transgenic mice. Oncotarget 2017;8:56228-42. [PMID: 28915586 DOI: 10.18632/oncotarget.17280] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
451 Kojiro M. The evolution of pathologic features of hepatocellular carcinoma. Viruses and Liver Cancer. Elsevier; 2002. pp. 113-22. [DOI: 10.1016/s0168-7069(02)06070-6] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
452 Nikolaeva LI, Blokhina NP, Tsurikova NN, Voronkova NV, Miminoshvili MI, Braginsky DM, Yastrebova ON, Booynitskaya OB, Isaeva OV, Michailov MI, Archakov AI. Virus-specific antibody titres in different phases of hepatitis C virus infection. J Viral Hepat 2002;9:429-37. [DOI: 10.1046/j.1365-2893.2002.00369.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
453 Kusakabe S, Suzuki T, Sugiyama Y, Haga S, Horike K, Tokunaga M, Hirano J, Zhang H, Chen DV, Ishiga H, Komoda Y, Ono C, Fukuhara T, Yamamoto M, Ikawa M, Satoh T, Akira S, Tanaka T, Moriishi K, Fukai M, Taketomi A, Yoshio S, Kanto T, Suzuki T, Okamoto T, Matsuura Y. USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet Formation. J Virol 2019;93:e01708-18. [PMID: 30626683 DOI: 10.1128/JVI.01708-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
454 Kumar D, Farrell GC, Kench J, George J. Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C. J Gastroenterol Hepatol. 2005;20:1395-1400. [PMID: 16105127 DOI: 10.1111/j.1440-1746.2005.04007.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
455 Panebianco C, Saracino C, Pazienza V. Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression. Tumour Biol 2014;35:7307-15. [PMID: 24833096 DOI: 10.1007/s13277-014-2075-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
456 Lyra AC, Fan X, Di Bisceglie AM. Molecular biology and clinical implication of hepatitis C virus. Braz J Med Biol Res 2004;37:691-5. [PMID: 15107931 DOI: 10.1590/s0100-879x2004000500010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
457 Yeh CT, Chen TC, Chang ML, Hsu CW, Yeh TS, Lee WC, Huang SF, Tsai CC. Identification of NV-F virus DNA in hepatocellular carcinoma. J Med Virol 2007;79:92-6. [PMID: 17133558 DOI: 10.1002/jmv.20763] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
458 Yan X, Battaglia S, Boucreux D, Chen Z, Brechot C, Pavio N. Mapping of the interacting domains of hepatitis C virus core protein and the double-stranded RNA-activated protein kinase PKR. Virus Research 2007;125:79-87. [DOI: 10.1016/j.virusres.2006.12.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
459 Machida K, Tsukiyama-Kohara K, Sekiguch S, Seike E, Tóne S, Hayashi Y, Tobita Y, Kasama Y, Shimizu M, Takahashi H. Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins. Gastroenterology. 2009;137:285-96, 296.e1-11. [PMID: 19362089 DOI: 10.1053/j.gastro.2009.03.061] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
460 Watashi K, Hijikata M, Tagawa A, Doi T, Marusawa H, Shimotohno K. Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus. Mol Cell Biol 2003;23:7498-509. [PMID: 14559998 DOI: 10.1128/MCB.23.21.7498-7509.2003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
461 Yoshida I, Oka K, Hidajat R, Nagano-Fujii M, Ishido S, Hotta H. Inhibition of p21/Waf1/Cip1/Sdi1 expression by hepatitis C virus core protein. Microbiol Immunol. 2001;45:689-697. [PMID: 11762751 DOI: 10.1111/j.1348-0421.2001.tb01303.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
462 De Francesco R. Molecular virology of the hepatitis C virus. Journal of Hepatology 1999;31:47-53. [DOI: 10.1016/s0168-8278(99)80374-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
463 Ray RB, Meyer K, Ray R. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology. 2000;271:197-204. [PMID: 10814584 DOI: 10.1006/viro.2000.0295] [Cited by in Crossref: 119] [Cited by in F6Publishing: 123] [Article Influence: 5.7] [Reference Citation Analysis]
464 Rockstroh JK, Spengler U. HIV and hepatitis C virus co-infection. The Lancet Infectious Diseases 2004;4:437-44. [DOI: 10.1016/s1473-3099(04)01059-x] [Cited by in Crossref: 120] [Cited by in F6Publishing: 36] [Article Influence: 7.1] [Reference Citation Analysis]
465 Benegiamo G, Mazzoccoli G, Cappello F, Rappa F, Scibetta N, Oben J, Greco A, Williams R, Andriulli A, Vinciguerra M, Pazienza V. Mutual antagonism between circadian protein period 2 and hepatitis C virus replication in hepatocytes. PLoS One 2013;8:e60527. [PMID: 23593233 DOI: 10.1371/journal.pone.0060527] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
466 Kitase A, Hino K, Furutani T, Okuda M, Gondo T, Hidaka I, Hara Y, Yamaguchi Y, Okita K. In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis. J Gastroenterol. 2005;40:617-624. [PMID: 16007396 DOI: 10.1007/s00535-005-1596-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
467 Chan SW. Unfolded protein response in hepatitis C virus infection. Front Microbiol. 2014;5:233. [PMID: 24904547 DOI: 10.3389/fmicb.2014.00233] [Cited by in Crossref: 21] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
468 Oka K, Nagano-fujii M, Yoshida I, Hidajat R, Deng L, Akutsu M, Hotta H. Hepatitis C Virus Core Protein Selectively Inhibits Synthesis and Accumulation of p21/Waf1 and Certain Nuclear Proteins. Microbiology and Immunology 2003;47:429-38. [DOI: 10.1111/j.1348-0421.2003.tb03380.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
469 Sasaki Y. Does oxidative stress participate in the development of hepatocellular carcinoma? J Gastroenterol. 2006;41:1135-1148. [PMID: 17287893 DOI: 10.1007/s00535-006-1982-z] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
470 Bralet MP, Régimbeau JM, Pineau P, Dubois S, Loas G, Degos F, Valla D, Belghiti J, Degott C, Terris B. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology. 2000;32:200-204. [PMID: 10915724 DOI: 10.1053/jhep.2000.9033] [Cited by in Crossref: 160] [Cited by in F6Publishing: 146] [Article Influence: 7.6] [Reference Citation Analysis]
471 Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller NE. Effect of hepatitis C virus infection on the risk of non-Hodgkin’s lymphoma: a meta-analysis of epidemiological studies. Cancer Sci. 2004;95:745-752. [PMID: 15471561 DOI: 10.1111/j.1349-7006.2004.tb03256.x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 140] [Article Influence: 9.1] [Reference Citation Analysis]
472 Cerutti A, Maillard P, Minisini R, Vidalain PO, Roohvand F, Pecheur EI, Pirisi M, Budkowska A. Identification of a functional, CRM-1-dependent nuclear export signal in hepatitis C virus core protein. PLoS One 2011;6:e25854. [PMID: 22039426 DOI: 10.1371/journal.pone.0025854] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
473 Basu A, Steele R, Ray R, Ray RB. Functional properties of a 16 kDa protein translated from an alternative open reading frame of the core-encoding genomic region of hepatitis C virus. J Gen Virol. 2004;85:2299-2306. [PMID: 15269371 DOI: 10.1099/vir.0.80028-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
474 Link T, Iwakuma T. Roles of p53 in extrinsic factor-induced liver carcinogenesis. Hepatoma Res 2017;3:95-104. [PMID: 30123836 DOI: 10.20517/2394-5079.2017.07] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
475 Kramer MG, Hernandez-alcoceba R, Qian C, Prieto J. Evaluation of hepatocellular carcinoma models for preclinical studies. Drug Discovery Today: Disease Models 2005;2:41-9. [DOI: 10.1016/j.ddmod.2005.05.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
476 Rustagi T, Zarookian EI, Qasba O, Diez LF. Chronic hepatitis C as a risk factor for colorectal adenoma. Int J Colorectal Dis 2014;29:75-80. [PMID: 23982424 DOI: 10.1007/s00384-013-1763-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
477 Quiroga AD, Lehner R. Liver triacylglycerol lipases. Biochim Biophys Acta 2012;1821:762-9. [PMID: 21963564 DOI: 10.1016/j.bbalip.2011.09.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
478 Gómez-Gonzalo M, Benedicto I, Carretero M, Lara-Pezzi E, Maldonado-Rodríguez A, Moreno-Otero R, Lai MM, López-Cabrera M. Hepatitis C virus core protein regulates p300/CBP co-activation function. Possible role in the regulation of NF-AT1 transcriptional activity. Virology. 2004;328:120-130. [PMID: 15380363 DOI: 10.1016/j.virol.2004.06.044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
479 Kobayashi S, Matsushita K, Saigo K, Urashima T, Asano T, Hayashi H, Ochiai T. P21WAF1/CIP1 messenger RNA expression in hepatitis B, C virus-infected human hepatocellular carcinoma tissues. Cancer 2001;91:2096-103. [PMID: 11391590 DOI: 10.1002/1097-0142(20010601)91:11<2096::aid-cncr1237>3.0.co;2-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
480 Kimura K, Nakayama M, Naito I, Komiyama T, Ichimura K, Asano H, Tsukuda K, Ohtsuka A, Oohashi T, Miyoshi S, Ninomiya Y. Human collagen XV is a prominent histopathological component of sinusoidal capillarization in hepatocellular carcinogenesis. Int J Clin Oncol 2016;21:302-9. [DOI: 10.1007/s10147-015-0888-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
481 O'Brien A, Zhou T, Tan C, Alpini G, Glaser S. Role of Non-Coding RNAs in the Progression of Liver Cancer: Evidence from Experimental Models. Cancers (Basel) 2019;11:E1652. [PMID: 31731549 DOI: 10.3390/cancers11111652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
482 Basu A, Meyer K, Lai KK, Saito K, Di Bisceglie AM, Grosso LE, Ray RB, Ray R. Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. Virology. 2006;349:347-358. [PMID: 16545852 DOI: 10.1016/j.virol.2006.02.023] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 3.5] [Reference Citation Analysis]
483 Muriel P. Role of free radicals in liver diseases. Hepatol Int. 2009;3:526-536. [PMID: 19941170 DOI: 10.1007/s12072-009-9158-6] [Cited by in Crossref: 209] [Cited by in F6Publishing: 174] [Article Influence: 17.4] [Reference Citation Analysis]
484 Okabe H, Ikai I, Matsuo K, Satoh S, Momoi H, Kamikawa T, Katsura N, Nishitai R, Takeyama O, Fukumoto M. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors. Hepatology. 2000;31:1073-1079. [PMID: 10796882 DOI: 10.1053/he.2000.6409] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 3.4] [Reference Citation Analysis]
485 Campbell RV, Yang Y, Wang T, Rachamallu A, Li Y, Watowich SJ, Weinman SA. Chapter 20 Effects of hepatitis C core protein on mitochondrial electron transport and production of reactive oxygen species. Methods Enzymol 2009;456:363-80. [PMID: 19348899 DOI: 10.1016/S0076-6879(08)04420-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
486 Malaguarnera M, Gargante MP, Risino C, Ranno S, Berretta M, Cannizzaro MA, Costanzo M, Fricia T, Rampello E, Romano M. Hepatitis C virus in elderly cancer patients. Eur J Intern Med. 2006;17:325-329. [PMID: 16864006 DOI: 10.1016/j.ejim.2006.02.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
487 Klopstock N, Katzenellenbogen M, Pappo O, Sklair-Levy M, Olam D, Mizrahi L, Potikha T, Galun E, Goldenberg D. HCV tumor promoting effect is dependent on host genetic background. PLoS One. 2009;4:e5025. [PMID: 19340302 DOI: 10.1371/journal.pone.0005025] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
488 Boulant S, Vanbelle C, Ebel C, Penin F, Lavergne J. Hepatitis C Virus Core Protein Is a Dimeric Alpha-Helical Protein Exhibiting Membrane Protein Features. J Virol 2005;79:11353-65. [DOI: 10.1128/jvi.79.17.11353-11365.2005] [Cited by in Crossref: 106] [Cited by in F6Publishing: 60] [Article Influence: 6.6] [Reference Citation Analysis]
489 Kern MA, Breuhahn K, Schirmacher P. Molecular pathogenesis of human hepatocellular carcinoma. Adv Cancer Res. 2002;86:67-112. [PMID: 12374281 DOI: 10.1016/s0065-230x(02)86003-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
490 Simula MP, Caggiari L, Gloghini A, De Re V. HCV-related immunocytoma and type II mixed cryoglobulinemia-associated autoantigens. Ann N Y Acad Sci. 2007;1110:121-130. [PMID: 17911427 DOI: 10.1196/annals.1423.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
491 Matsuzaki K, Seki T, Okazaki K. TGF-β signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases. J Gastroenterol 2014;49:971-81. [PMID: 24263677 DOI: 10.1007/s00535-013-0910-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
492 Uchida Y, Kouyama J, Naiki K, Sugawara K, Ando S, Nakao M, Motoya D, Inao M, Imai Y, Nakayama N, Mochida S. Significance of variants associated with resistance to NS5A inhibitors in Japanese patients with genotype 1b hepatitis C virus infection as evaluated using cycling-probe real-time PCR combined with direct sequencing. J Gastroenterol 2016;51:260-70. [DOI: 10.1007/s00535-015-1106-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
493 Gupta S, Singh R. Analysis of the virus dynamics model reveals that early treatment of HCV infection may lead to the sustained virological response. PLoS One 2012;7:e41209. [PMID: 22911761 DOI: 10.1371/journal.pone.0041209] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
494 Duong FH, Christen V, Lin S, Heim MH. Hepatitis C virus-induced up-regulation of protein phosphatase 2A inhibits histone modification and DNA damage repair. Hepatology. 2010;51:741-751. [PMID: 20043320 DOI: 10.1002/hep.23388] [Cited by in Crossref: 11] [Cited by in F6Publishing: 31] [Article Influence: 1.0] [Reference Citation Analysis]
495 Karachristos A, Liloglou T, Field JK, Deligiorgi E, Kouskouni E, Spandidos DA. Microsatellite instability and p53 mutations in hepatocellular carcinoma. Mol Cell Biol Res Commun 1999;2:155-61. [PMID: 10662591 DOI: 10.1006/mcbr.1999.0170] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
496 Pellerin M, Lopez-Aguirre Y, Penin F, Dhumeaux D, Pawlotsky JM. Hepatitis C virus quasispecies variability modulates nonstructural protein 5A transcriptional activation, pointing to cellular compartmentalization of virus-host interactions. J Virol 2004;78:4617-27. [PMID: 15078944 DOI: 10.1128/jvi.78.9.4617-4627.2004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
497 Kim MN, Kim BK, Han KH. Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia-Pacific region. J Gastroenterol 2013;48:681-8. [PMID: 23463401 DOI: 10.1007/s00535-013-0770-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
498 Kato T, Miyamoto M, Date T, Yasui K, Taya C, Yonekawa H, Ohue C, Yagi S, Seki E, Hirano T. Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice. Cancer Sci. 2003;94:679-685. [PMID: 12901792 DOI: 10.1111/j.1349-7006.2003.tb01502.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
499 Zhou JJ, Meng Z, He XY, Cheng D, Ye HL, Deng XG, Chen RF. Hepatitis C virus core protein increases Snail expression and induces epithelial-mesenchymal transition through the signal transducer and activator of transcription 3 pathway in hepatoma cells. Hepatol Res 2017;47:574-83. [PMID: 27381678 DOI: 10.1111/hepr.12771] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
500 Pekow JR, Bhan AK, Zheng H, Chung RT. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer. 2007;109:2490-2496. [PMID: 17487861 DOI: 10.1002/cncr.22701] [Cited by in Crossref: 140] [Cited by in F6Publishing: 119] [Article Influence: 10.0] [Reference Citation Analysis]
501 Spaziani A, Alisi A, Sanna D, Balsano C. Role of p38 MAPK and RNA-dependent Protein Kinase (PKR) in Hepatitis C Virus Core-dependent Nuclear Delocalization of Cyclin B1. Journal of Biological Chemistry 2006;281:10983-9. [DOI: 10.1074/jbc.m512536200] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
502 Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003;22:5093-107. [DOI: 10.1038/sj.onc.1206557] [Cited by in Crossref: 350] [Cited by in F6Publishing: 321] [Article Influence: 19.4] [Reference Citation Analysis]
503 Wu L, Tang Z, Li Y. Experimental models of hepatocellular carcinoma: developments and evolution. J Cancer Res Clin Oncol 2009;135:969-81. [DOI: 10.1007/s00432-009-0591-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
504 Dabo S, Meurs EF. dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection. Viruses 2012;4:2598-635. [PMID: 23202496 DOI: 10.3390/v4112598] [Cited by in Crossref: 112] [Cited by in F6Publishing: 98] [Article Influence: 12.4] [Reference Citation Analysis]
505 Zhao P, Malik S, Xing S. Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC). Front Oncol 2021;11:677926. [PMID: 34336665 DOI: 10.3389/fonc.2021.677926] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
506 Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Kaneko S. Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C. Hepatology. 2006;44:1122-1138. [PMID: 17058214 DOI: 10.1002/hep.21383] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 4.2] [Reference Citation Analysis]
507 Lanford RE, Bigger C. Advances in model systems for hepatitis C virus research. Virology 2002;293:1-9. [PMID: 11853392 DOI: 10.1006/viro.2001.1316] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
508 Bouchard MJ, Navas-Martin S. Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett 2011;305:123-43. [PMID: 21168955 DOI: 10.1016/j.canlet.2010.11.014] [Cited by in Crossref: 97] [Cited by in F6Publishing: 93] [Article Influence: 8.8] [Reference Citation Analysis]
509 Miura K, Ohnishi H. Nonalcoholic fatty liver disease: from lipid profile to treatment. Clin J Gastroenterol 2012;5:313-21. [DOI: 10.1007/s12328-012-0315-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
510 Aizawa S, Okamoto T, Sugiyama Y, Kouwaki T, Ito A, Suzuki T, Ono C, Fukuhara T, Yamamoto M, Okochi M, Hiraga N, Imamura M, Chayama K, Suzuki R, Shoji I, Moriishi K, Moriya K, Koike K, Matsuura Y. TRC8-dependent degradation of hepatitis C virus immature core protein regulates viral propagation and pathogenesis. Nat Commun 2016;7:11379. [PMID: 27142248 DOI: 10.1038/ncomms11379] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
511 Akuta N, Suzuki F, Seko Y, Kawamura Y, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Hara T, Kobayashi M. Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis. Hepatology. 2012;56:2134-2141. [PMID: 22806754 DOI: 10.1002/hep.25949] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
512 Callegari E, Gramantieri L, Domenicali M, D’Abundo L, Sabbioni S, Negrini M. MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. Cell Death Differ. 2015;22:46-57. [PMID: 25190143 DOI: 10.1038/cdd.2014.136] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 12.1] [Reference Citation Analysis]
513 McCaughan GW, Zekry A. Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection. Transpl Infect Dis. 2000;2:166-185. [PMID: 11429029 DOI: 10.1034/j.1399-3062.2000.020403.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
514 Shiraha H, Yamamoto K, Namba M. Human hepatocyte carcinogenesis (review). Int J Oncol. 2013;42:1133-1138. [PMID: 23426905 DOI: 10.3892/ijo.2013.1829] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 9.4] [Reference Citation Analysis]
515 Moriya K, Miyoshi H, Tsutsumi T, Shinzawa S, Fujie H, Shintani Y, Yotsuyanagi H, Moriishi K, Matsuura Y, Suzuki T. Tacrolimus ameliorates metabolic disturbance and oxidative stress caused by hepatitis C virus core protein: analysis using mouse model and cultured cells. Am J Pathol. 2009;175:1515-1524. [PMID: 19729476 DOI: 10.2353/ajpath.2009.090102] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
516 Liu J, Ding X, Tang J, Cao Y, Hu P, Zhou F, Shan X, Cai X, Chen Q, Ling N. Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells. PLoS One. 2011;6:e27496. [PMID: 22110662 DOI: 10.1371/journal.pone.0027496] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 8.0] [Reference Citation Analysis]
517 Hu WT, Li HC, Lee SK, Ma HC, Yang CH, Chen HL, Lo SY. Both core and F proteins of hepatitis C virus could enhance cell proliferation in transgenic mice. Biochem Biophys Res Commun. 2013;435:147-152. [PMID: 23628415 DOI: 10.1016/j.bbrc.2013.04.059] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
518 Nguyen H, Sankaran S, Dandekar S. Hepatitis C virus core protein induces expression of genes regulating immune evasion and anti-apoptosis in hepatocytes. Virology. 2006;354:58-68. [PMID: 16876223 DOI: 10.1016/j.virol.2006.04.028] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
519 Wang Z, Ceniccola K, Florea L, Wang BD, Lee NH, Kumar A. Viral non-coding RNA inhibits HNF4α expression in HCV associated hepatocellular carcinoma. Infect Agent Cancer 2015;10:19. [PMID: 26157476 DOI: 10.1186/s13027-015-0014-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
520 Macdonald GA. Pathogenesis of Hepatocellular Carcinoma. Clinics in Liver Disease 2001;5:69-85. [DOI: 10.1016/s1089-3261(05)70154-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
521 Joo M, Hahn YS. Animal models for immune defects caused by hepatitis C virus. Molecular Medicine Today 2000;6:176-7. [DOI: 10.1016/s1357-4310(00)01678-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
522 Longerich T, Mueller MM, Breuhahn K, Schirmacher P, Benner A, Heiss C. Oncogenetic tree modeling of human hepatocarcinogenesis. Int J Cancer 2012;130:575-83. [PMID: 21400513 DOI: 10.1002/ijc.26063] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
523 Lu W, Lo SY, Chen M, Wu K, Fung YK, Ou JH. Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology. 1999;264:134-141. [PMID: 10544138 DOI: 10.1006/viro.1999.9979] [Cited by in Crossref: 99] [Cited by in F6Publishing: 91] [Article Influence: 4.5] [Reference Citation Analysis]
524 Yoshida Y, Imai Y, Sawai Y, Saito Y, Cao J, Fukuda K, Niki E. Hydroxyoctadecadienoic acid as a potential biomarker for oxidative stress in patients with chronic hepatitis C. J Gastroenterol Hepatol. 2010;25:107-115. [PMID: 19780883 DOI: 10.1111/j.1440-1746.2009.05928.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
525 Rossi L, Leveri M, Gritti C, De Silvestri A, Zavaglia C, Sonzogni L, Silvestri L, Civardi E, Mondelli MU, Silini EM. Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients. J Hepatol 2003;39:564-70. [PMID: 12971967 DOI: 10.1016/s0168-8278(03)00355-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
526 Yamada M, Shiroeda H, Hayashi R, Yano H, Sato K, Tsutsumi M, Arisawa T. Survival rates of early-stage HCV-related liver cirrhosis patients without hepatocellular carcinoma are decreased by alcohol. J Clin Biochem Nutr 2011;48:167-9. [PMID: 21373271 DOI: 10.3164/jcbn.09-119GFR] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
527 Morales-Sánchez A, Fuentes-Pananá EM. Human viruses and cancer. Viruses. 2014;6:4047-4079. [PMID: 25341666 DOI: 10.3390/v6104047] [Cited by in Crossref: 84] [Cited by in F6Publishing: 62] [Article Influence: 12.0] [Reference Citation Analysis]
528 Giannini C, Bréchot C. Hepatitis C virus biology. Cell Death Differ 2003;10:S27-38. [DOI: 10.1038/sj.cdd.4401121] [Cited by in Crossref: 126] [Cited by in F6Publishing: 123] [Article Influence: 7.0] [Reference Citation Analysis]
529 Jhaveri R, McHutchison J, Patel K, Qiang G, Diehl AM. Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation. J Infect Dis. 2008;197:283-291. [PMID: 18177246 DOI: 10.1086/524846] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
530 Lim EJ, Torresi J. Prevention of Hepatitis C Virus Infection and Liver Cancer. Recent Results Cancer Res 2021;217:107-40. [PMID: 33200364 DOI: 10.1007/978-3-030-57362-1_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
531 Geller SA. Hepatitis B and hepatitis C. Clin Liver Dis 2002;6:317-34, v. [PMID: 12122858 DOI: 10.1016/s1089-3261(02)00008-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
532 Nkontchou G, Ziol M, Aout M, Lhabadie M, Baazia Y, Mahmoudi A, Roulot D, Ganne-Carrie N, Grando-Lemaire V, Trinchet JC, Gordien E, Vicaut E, Baghad I, Beaugrand M. HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis. J Viral Hepat. 2011;18:e516-e522. [PMID: 21914071 DOI: 10.1111/j.1365-2893.2011.01441.x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 100] [Article Influence: 12.8] [Reference Citation Analysis]
533 Zhou L, Wen J, Huang Z, Nice EC, Huang C, Zhang H, Li Q. Redox proteomics screening cellular factors associated with oxidative stress in hepatocarcinogenesis. Proteomics Clin Appl 2017;11. [PMID: 27763721 DOI: 10.1002/prca.201600089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
534 Honda M, Kaneko S, Shimazaki T, Matsushita E, Kobayashi K, Ping LH, Zhang HC, Lemon SM. Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. Hepatology. 2000;31:1351-1359. [PMID: 10827163 DOI: 10.1053/jhep.2000.7985] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 4.6] [Reference Citation Analysis]
535 Yi Z, Yuan Z. Hepatitis C Virus-Associated Cancers. Adv Exp Med Biol. 2017;1018:129-146. [PMID: 29052135 DOI: 10.1007/978-981-10-5765-6_8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
536 Farrell GC. Hepatocellular carcinoma after sustained response to interferon in non‐cirrhotic hepatitis C: Flaws in the cure, or a clue to the flaws? Journal of Gastroenterology and Hepatology 2001;14:833-7. [DOI: 10.1046/j.1440-1746.1999.01977.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
537 Saikia A, Bose M, Barman NN, Deka M, Thangkhiew RS, Bose S. Molecular epidemiology of HBV infection in chronic hepatitis B virus infected patients in northeast India. J Med Virol 2015;87:1539-48. [PMID: 25919572 DOI: 10.1002/jmv.24207] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
538 Lai MMC, Ware CF. Hepatitis C Virus Core Protein: Possible Roles in Viral Pathogenesis. In: Hagedorn CH, Rice CM, editors. The Hepatitis C Viruses. Berlin: Springer Berlin Heidelberg; 2000. pp. 117-34. [DOI: 10.1007/978-3-642-59605-6_6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 43] [Article Influence: 1.4] [Reference Citation Analysis]
539 Disson O, Haouzi D, Desagher S, Loesch K, Hahne M, Kremer EJ, Jacquet C, Lemon SM, Hibner U, Lerat H. Impaired clearance of virus-infected hepatocytes in transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology. 2004;126:859-872. [PMID: 14988840 DOI: 10.1053/j.gastro.2003.12.005] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 3.2] [Reference Citation Analysis]
540 Ratnoglik SL, Jiang DP, Aoki C, Sudarmono P, Shoji I, Deng L, Hotta H. Induction of cell-mediated immune responses in mice by DNA vaccines that express hepatitis C virus NS3 mutants lacking serine protease and NTPase/RNA helicase activities. PLoS One 2014;9:e98877. [PMID: 24901478 DOI: 10.1371/journal.pone.0098877] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
541 Mirandola S, Osterreicher CH, Marcolongo M, Datz C, Aigner E, Schlabrakowski A, Realdon S, Gerotto M, Alberti A, Stickel F. Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C. Liver Int. 2009;29:557-565. [PMID: 19018985 DOI: 10.1111/j.1478-3231.2008.01892.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
542 Hoshida Y, Shiratori Y, Omata M. Cost-effectiveness of adjuvant interferon therapy after surgical resection of Hepatitis C-related hepatocellular carcinoma: Interferon after resection of HCC. Liver 2002;22:479-85. [DOI: 10.1034/j.1600-0676.2002.01736.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
543 Nakai M, Oshiumi H, Funami K, Okamoto M, Matsumoto M, Seya T, Sakamoto N. Interferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV). Sensors (Basel) 2015;15:27160-73. [PMID: 26512676 DOI: 10.3390/s151027160] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
544 Nitahara-Kasahara Y, Fukasawa M, Shinkai-Ouchi F, Sato S, Suzuki T, Murakami K, Wakita T, Hanada K, Miyamura T, Nishijima M. Cellular vimentin content regulates the protein level of hepatitis C virus core protein and the hepatitis C virus production in cultured cells. Virology 2009;383:319-27. [PMID: 19013628 DOI: 10.1016/j.virol.2008.10.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
545 Kao CF, Chen SY, Lee YH. Activation of RNA polymerase I transcription by hepatitis C virus core protein. J Biomed Sci. 2004;11:72-94. [PMID: 14730212 DOI: 10.1007/bf02256551] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
546 Teoh WW, Xie M, Vijayaraghavan A, Yaligar J, Tong WM, Goh LK, Sabapathy K. Molecular characterization of hepatocarcinogenesis using mouse models. Dis Model Mech 2015;8:743-53. [PMID: 26035378 DOI: 10.1242/dmm.017624] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
547 Yoshida K, Murata M, Yamaguchi T, Matsuzaki K. TGF-β/Smad signaling during hepatic fibro-carcinogenesis (review). Int J Oncol 2014;45:1363-71. [PMID: 25050845 DOI: 10.3892/ijo.2014.2552] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 10.9] [Reference Citation Analysis]
548 Strosberg AD, Kota S, Takahashi V, Snyder JK, Mousseau G. Core as a novel viral target for hepatitis C drugs. Viruses 2010;2:1734-51. [PMID: 21994704 DOI: 10.3390/v2081734] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
549 Koike K. Pathogenesis of HCV-associated HCC: Dual-pass carcinogenesis through activation of oxidative stress and intracellular signaling. Hepatol Res. 2007;37 Suppl 2:S115-S120. [PMID: 17877471 DOI: 10.1111/j.1872-034x.2007.00173.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
550 Roessler S, Budhu A, Wang XW. Future of molecular profiling of human hepatocellular carcinoma. Future Oncol. 2007;3:429-439. [PMID: 17661718 DOI: 10.2217/14796694.3.4.429] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
551 Liu W, Chen JR, Hsu CH, Li YH, Chen YM, Lin CY, Huang SJ, Chang ZK, Chen YC, Lin CH, Gong HY, Lin CC, Kawakami K, Wu JL. A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver. Hepatology. 2012;56:2268-2276. [PMID: 22729936 DOI: 10.1002/hep.25914] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 5.8] [Reference Citation Analysis]
552 Furuta K, Sato S, Yamauchi T, Kakumu S. Changes in intrahepatic gene expression profiles from chronic hepatitis to hepatocellular carcinoma in patients with hepatitis C virus infection. Hepatology Research 2008;38:673-82. [DOI: 10.1111/j.1872-034x.2008.00328.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
553 Hurtado-Cordovi J, Davis-Yadley AH, Lipka S, Vardaros M, Shen H. Association between chronic hepatitis C and hepatitis C/HIV co-infection and the development of colorectal adenomas. J Gastrointest Oncol 2016;7:609-14. [PMID: 27563452 DOI: 10.21037/jgo.2016.03.11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
554 Aoki H, Hayashi J, Moriyama M, Arakawa Y, Hino O. Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. J Virol. 2000;74:1736-1741. [PMID: 10644344 DOI: 10.1128/jvi.74.4.1736-1741.2000] [Cited by in Crossref: 117] [Cited by in F6Publishing: 44] [Article Influence: 5.6] [Reference Citation Analysis]
555 Sedeno-Monge V, Vallejo-Ruiz V, Sosa-Jurado F, Santos-Lopez G. Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular carcinoma. J Biosci 2017;42:509-21. [PMID: 29358564 DOI: 10.1007/s12038-017-9695-4] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
556 Bailey MA, Brunt EM. Hepatocellular carcinoma: predisposing conditions and precursor lesions. Gastroenterol Clin North Am 2002;31:641-62. [PMID: 12134622 DOI: 10.1016/s0889-8553(02)00017-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
557 Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, Lin SM, Chen CJ. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst. 2001;93:1644-1651. [PMID: 11698569 DOI: 10.1093/jnci/93.21.1644] [Cited by in Crossref: 111] [Cited by in F6Publishing: 100] [Article Influence: 5.6] [Reference Citation Analysis]
558 Akuta N, Suzuki F, Hirakawa M, Kawamura Y, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H. Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy. J Med Virol 2011;83:1016-22. [DOI: 10.1002/jmv.22094] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
559 Lee AY, Manning WC, Arian CL, Polakos NK, Barajas JL, Ulmer JB, Houghton M, Paliard X. Priming of hepatitis C virus-specific cytotoxic T lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA. Hepatology. 2000;31:1327-1333. [PMID: 10827159 DOI: 10.1053/jhep.2000.7297] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
560 El-Shamy A, Shindo M, Shoji I, Deng L, Okuno T, Hotta H. Polymorphisms of the core, NS3, and NS5A proteins of hepatitis C virus genotype 1b associate with development of hepatocellular carcinoma. Hepatology. 2013;58:555-563. [PMID: 23281009 DOI: 10.1002/hep.26205] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
561 Turk Wensveen T, Gašparini D, Rahelić D, Wensveen FM. Type 2 diabetes and viral infection; cause and effect of disease. Diabetes Res Clin Pract 2021;172:108637. [PMID: 33352263 DOI: 10.1016/j.diabres.2020.108637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
562 Martin J, Dufour JF. Tumor suppressor and hepatocellular carcinoma. World J Gastroenterol. 2008;14:1720-1733. [PMID: 18350603 DOI: 10.3748/wjg.14.1720] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
563 Levander S, Holmström F, Frelin L, Ahlén G, Rupp D, Long G, Bartenschlager R, Sällberg M. Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model. Gut 2018;67:1525-35. [PMID: 28646094 DOI: 10.1136/gutjnl-2016-313579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
564 Li K, Wang L, Cheng J, Lu YY, Zhang LX, Mu JS, Hong Y, Liu Y, Duan HJ, Wang G. Interaction between hepatitis C virus core protein and translin protein-a possible molecular mechanism for hepatocellular carcinoma and lymphoma caused by hepatitis C virus. World J Gastroenterol. 2003;9:300-303. [PMID: 12532453 DOI: 10.3748/wjg.v9.i2.300] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
565 Choi J, Corder NL, Koduru B, Wang Y. Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma. Free Radic Biol Med 2014;72:267-84. [PMID: 24816297 DOI: 10.1016/j.freeradbiomed.2014.04.020] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 8.3] [Reference Citation Analysis]
566 Midorikawa Y, Sugiyama Y, Aburatani H. Screening of liver-targeted drugs. Expert Opinion on Drug Discovery 2008;3:643-54. [DOI: 10.1517/17460441.3.6.643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
567 McLauchlan J. Lipid droplets and hepatitis C virus infection. Biochim Biophys Acta 2009;1791:552-9. [PMID: 19167518 DOI: 10.1016/j.bbalip.2008.12.012] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
568 Tiwari I, Yoon MH, Park BJ, Jang KL. Hepatitis C virus core protein induces epithelial-mesenchymal transition in human hepatocytes by upregulating E12/E47 levels. Cancer Lett 2015;362:131-8. [PMID: 25817725 DOI: 10.1016/j.canlet.2015.03.032] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
569 Cao W, Sun B, Feitelson MA, Wu T, Tur-Kaspa R, Fan Q. Hepatitis C virus targets over-expression of arginase I in hepatocarcinogenesis. Int J Cancer 2009;124:2886-92. [PMID: 19253371 DOI: 10.1002/ijc.24265] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
570 Takahashi Y, Fukusato T. Animal Models of Liver Diseases. Animal Models for the Study of Human Disease. Elsevier; 2017. pp. 313-39. [DOI: 10.1016/b978-0-12-809468-6.00013-9] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
571 Kapadia SB, Chisari FV. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci USA. 2005;102:2561-2566. [PMID: 15699349 DOI: 10.1073/pnas.0409834102] [Cited by in Crossref: 363] [Cited by in F6Publishing: 350] [Article Influence: 22.7] [Reference Citation Analysis]
572 Chami M, Oulès B, Paterlini-Bréchot P. Cytobiological consequences of calcium-signaling alterations induced by human viral proteins. Biochim Biophys Acta 2006;1763:1344-62. [PMID: 17059849 DOI: 10.1016/j.bbamcr.2006.09.025] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
573 Hourioux C, Ait-Goughoulte M, Patient R, Fouquenet D, Arcanger-Doudet F, Brand D, Martin A, Roingeard P. Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane. Cell Microbiol 2007;9:1014-27. [PMID: 17257269 DOI: 10.1111/j.1462-5822.2006.00848.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
574 Ruggieri A, Franco M, Gatto I, Kumar A, Rapicetta M. Modulation of RANTES expression by HCV core protein in liver derived cell lines. BMC Gastroenterol 2007;7:21. [PMID: 17565659 DOI: 10.1186/1471-230X-7-21] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
575 Chang M, Chen T, Chang M, Yeh C. Cell cycle perturbation in the hepatocytes of HCV core transgenic mice following common bile duct ligation is associated with enhanced p21 expression. J Med Virol 2009;81:467-72. [DOI: 10.1002/jmv.21403] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
576 Sato C, Saito T, Misawa K, Katsumi T, Tomita K, Ishii R, Haga H, Okumoto K, Nishise Y, Watanabe H. Impaired mitochondrial β-oxidation in patients with chronic hepatitis C: relation with viral load and insulin resistance. BMC Gastroenterol. 2013;13:112. [PMID: 23841691 DOI: 10.1186/1471-230x-13-112] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
577 Li ZH, Tang QB, Wang J, Zhou L, Huang WL, Liu RY, Chen RF. Hepatitis C virus core protein induces malignant transformation of biliary epithelial cells by activating nuclear factor-kappaB pathway. J Gastroenterol Hepatol. 2010;25:1315-1320. [PMID: 20594262 DOI: 10.1111/j.1440-1746.2009.06201.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
578 Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TS, Lindsay KL, Levine AM, Lai MM. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 2003;77:2134-46. [PMID: 12525648 DOI: 10.1128/jvi.77.3.2134-2146.2003] [Cited by in Crossref: 196] [Cited by in F6Publishing: 87] [Article Influence: 10.9] [Reference Citation Analysis]
579 Polyak SJ. Hepatitis C virus–cell interactions and their role in pathogenesis. Clinics in Liver Disease 2003;7:67-88. [DOI: 10.1016/s1089-3261(02)00075-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
580 Farinati F, Cardin R, Fiorentino M, D'errico A, Grigioni W, Cecchetto A, Naccarato R. Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease. J Viral Hepat. 2001;8:34-40. [PMID: 11155150 DOI: 10.1046/j.1365-2893.2001.00267.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
581 Koike K, Moriya K, Matsuura Y. Animal models for hepatitis C and related liver disease. Hepatol Res 2010;40:69-82. [PMID: 20156300 DOI: 10.1111/j.1872-034X.2009.00593.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
582 Wangensteen KJ, Chang KM. Multiple Roles for Hepatitis B and C Viruses and the Host in the Development of Hepatocellular Carcinoma. Hepatology 2021;73 Suppl 1:27-37. [PMID: 32737895 DOI: 10.1002/hep.31481] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
583 Chen SY, Kao CF, Chen CM, Shih CM, Hsu MJ, Chao CH, Wang SH, You LR, Lee YH. Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J Biol Chem. 2003;278:591-607. [PMID: 12401801 DOI: 10.1074/jbc.m204241200] [Cited by in Crossref: 107] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
584 Blais DR, Lyn RK, Joyce MA, Rouleau Y, Steenbergen R, Barsby N, Zhu LF, Pegoraro AF, Stolow A, Tyrrell DL, Pezacki JP. Activity-based protein profiling identifies a host enzyme, carboxylesterase 1, which is differentially active during hepatitis C virus replication. J Biol Chem 2010;285:25602-12. [PMID: 20530478 DOI: 10.1074/jbc.M110.135483] [Cited by in Crossref: 50] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
585 Koike K. Hepatitis C virus infection can present with metabolic disease by inducing insulin resistance. Intervirology. 2006;49:51-57. [PMID: 16166789 DOI: 10.1159/000087263] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
586 Zender L, Kubicka S. Androgen receptor and hepatocarcinogenesis: what do we learn from HCC mouse models? Gastroenterology. 2008;135:738-740. [PMID: 18692055 DOI: 10.1053/j.gastro.2008.07.034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
587 Blindenbacher A, Duong FH, Hunziker L, Stutvoet ST, Wang X, Terracciano L, Moradpour D, Blum HE, Alonzi T, Tripodi M. Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. Gastroenterology. 2003;124:1465-1475. [PMID: 12730885 DOI: 10.1016/s0016-5085(03)00290-7] [Cited by in Crossref: 131] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
588 Brass V, Moradpour D, Blum HE. Molecular virology of hepatitis C virus (HCV): 2006 update. Int J Med Sci. 2006;3:29-34. [PMID: 16614739 DOI: 10.7150/ijms.3.29] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
589 Fujinaga H, Tsutsumi T, Yotsuyanagi H, Moriya K, Koike K. Hepatocarcinogenesis in Hepatitis C: HCV Shrewdly Exacerbates Oxidative Stress by Modulating both Production and Scavenging of Reactive Oxygen Species. Oncology 2011;81:11-7. [DOI: 10.1159/000333253] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
590 Ueno Y, Sollano JD, Farrell GC. Prevention of hepatocellular carcinoma complicating chronic hepatitis C. J Gastroenterol Hepatol 2009;24:531-6. [PMID: 19368633 DOI: 10.1111/j.1440-1746.2009.05814.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
591 Jahan S, Khaliq S, Ijaz B, Ahmad W, Hassan S. Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis. Virol J. 2011;8:155. [PMID: 21457561 DOI: 10.1186/1743-422x-8-155] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
592 Cho J, Baek W, Yang S, Chang J, Sung YC, Suh M. HCV core protein modulates Rb pathway through pRb down-regulation and E2F-1 up-regulation. Biochim Biophys Acta. 2001;1538:59-66. [PMID: 11341983 DOI: 10.1016/s0167-4889(00)00137-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
593 Suzuki T. Assembly of hepatitis C virus particles. Microbiol Immunol. 2011;55:12-18. [PMID: 21175769 DOI: 10.1111/j.1348-0421.2010.00274.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
594 Zhu AX, Chung RT. Hepatic steatosis in patients with chronic hepatitis C virus infection: Another risk factor for hepatocellular carcinoma? Cancer 2003;97:2948-50. [DOI: 10.1002/cncr.11440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
595 Okuda H. Hepatocellular carcinoma development in cirrhosis. Best Pract Res Clin Gastroenterol 2007;21:161-73. [PMID: 17223503 DOI: 10.1016/j.bpg.2006.07.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
596 Barone M, Maiorano E, Scavo M, Panella E, Castellaneta A, Napoli A, Francioso D, Di Leo A, Francavilla A. Effect of gonadectomy on HCC development in HBV transgenic mice. Digestive and Liver Disease 2009;41:150-5. [DOI: 10.1016/j.dld.2008.02.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
597 Kwak J, Choi JH, Jang KL. Hepatitis C virus Core overcomes all-trans retinoic acid-induced apoptosis in human hepatoma cells by inhibiting p14 expression via DNA methylation. Oncotarget 2017;8:85584-98. [PMID: 29156743 DOI: 10.18632/oncotarget.20337] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
598 Chin RI, Chen K, Usmani A, Chua C, Harris PK, Binkley MS, Azad TD, Dudley JC, Chaudhuri AA. Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA). Mol Diagn Ther 2019;23:311-31. [PMID: 30941670 DOI: 10.1007/s40291-019-00390-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 40.0] [Reference Citation Analysis]
599 El-Shamy A, Pendleton M, Eng FJ, Doyle EH, Bashir A, Branch AD. Impact of HCV core gene quasispecies on hepatocellular carcinoma risk among HALT-C trial patients. Sci Rep. 2016;6:27025. [PMID: 27246310 DOI: 10.1038/srep27025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
600 Cooke MS, Olinski R, Evans MD. Does measurement of oxidative damage to DNA have clinical significance? Clin Chim Acta 2006;365:30-49. [PMID: 16214123 DOI: 10.1016/j.cca.2005.09.009] [Cited by in Crossref: 170] [Cited by in F6Publishing: 140] [Article Influence: 10.6] [Reference Citation Analysis]
601 Majumder M, Steele R, Ghosh AK, Zhou XY, Thornburg L, Ray R, Phillips NJ, Ray RB. Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice. FEBS Lett. 2003;555:528-532. [PMID: 14675768 DOI: 10.1016/s0014-5793(03)01337-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
602 Hayes CN, Zhang P, Zhang Y, Chayama K. Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection. Viruses. 2018;10. [PMID: 30274202 DOI: 10.3390/v10100531] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
603 Ray RB, Ray R. Hepatitis C virus core protein: intriguing properties and functional relevance. FEMS Microbiol Lett. 2001;202:149-156. [PMID: 11520607 DOI: 10.1111/j.1574-6968.2001.tb10796.x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 106] [Article Influence: 5.3] [Reference Citation Analysis]
604 Shiratori Y, Yoshida H, Omata M. Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention. Expert Rev Anticancer Ther. 2001;1:277-290. [PMID: 12113033 DOI: 10.1586/14737140.1.2.277] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
605 Tanaka N, Moriya K, Kiyosawa K, Koike K, Gonzalez FJ, Aoyama T. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest. 2008;118:683-694. [PMID: 18188449 DOI: 10.1172/jci33594] [Cited by in Crossref: 32] [Cited by in F6Publishing: 101] [Article Influence: 2.5] [Reference Citation Analysis]
606 Sekiguchi S, Kimura K, Chiyo T, Ohtsuki T, Tobita Y, Tokunaga Y, Yasui F, Tsukiyama-Kohara K, Wakita T, Tanaka T. Immunization with a recombinant vaccinia virus that encodes nonstructural proteins of the hepatitis C virus suppresses viral protein levels in mouse liver. PLoS One. 2012;7:e51656. [PMID: 23284733 DOI: 10.1371/journal.pone.0051656] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
607 Ahmad W, Ijaz B, Javed FT, Gull S, Kausar H, Sarwar MT, Asad S, Shahid I, Sumrin A, Khaliq S. A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI). BMC Gastroenterol. 2011;11:44. [PMID: 21507271 DOI: 10.1186/1471-230x-11-44] [Cited by in Crossref: 51] [Cited by in F6Publishing: 21] [Article Influence: 5.1] [Reference Citation Analysis]
608 Barone M, Margiotta M, Scavo MP, Gentile A, Francioso D, Papagni S, Castellaneta A, Mallamaci R, Di Leo A, Francavilla A. Possible involvement of androgen receptor alterations in hepatocarcinogenesis. Dig Liver Dis 2009;41:665-70. [PMID: 19201267 DOI: 10.1016/j.dld.2008.12.099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
609 Cha RR, Lee SS, Lee CM, Ji SB, Jung HC, Cho HC, Kim JJ, Lee JM, Kim HJ, Ha CY, Kim HJ, Kim TH, Jung WT, Lee OJ. Clinical Features and Outcomes of Patients With Genotype 3 Hepatitis C Virus Infection in Korea: A Retrospective Observational Study. Medicine (Baltimore) 2016;95:e2755. [PMID: 26871824 DOI: 10.1097/MD.0000000000002755] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
610 Hofer H, Bankl HC, Wrba F, Steindl-munda P, Peck-radosavljevic M, Osterreicher C, Mueller C, Gangl A, Ferenci P. Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a. Am J Gastroenterology 2002;97:2880-5. [DOI: 10.1111/j.1572-0241.2002.07056.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 4.4] [Reference Citation Analysis]
611 Shimoike T, Mimori S, Tani H, Matsuura Y, Miyamura T. Interaction of Hepatitis C Virus Core Protein with Viral Sense RNA and Suppression of Its Translation. J Virol 1999;73:9718-25. [DOI: 10.1128/jvi.73.12.9718-9725.1999] [Cited by in Crossref: 124] [Cited by in F6Publishing: 57] [Article Influence: 5.6] [Reference Citation Analysis]
612 Forns X, Bukh J. The molecular biology of hepatitis C virus. Genotypes and quasispecies. Clin Liver Dis 1999;3:693-716, vii. [PMID: 11291246 DOI: 10.1016/s1089-3261(05)70234-8] [Cited by in Crossref: 58] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
613 Omura T, Yoshiyama M, Hayashi T, Nishiguchi S, Kaito M, Horiike S, Fukuda K, Inamoto S, Kitaura Y, Nakamura Y, Teragaki M, Tokuhisa T, Iwao H, Takeuchi K, Yoshikawa J. Core protein of hepatitis C virus induces cardiomyopathy. Circ Res 2005;96:148-50. [PMID: 15618537 DOI: 10.1161/01.RES.0000154263.70223.13] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
614 Mansouri A, Gattolliat CH, Asselah T. Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases. Gastroenterology 2018;155:629-47. [PMID: 30012333 DOI: 10.1053/j.gastro.2018.06.083] [Cited by in Crossref: 167] [Cited by in F6Publishing: 153] [Article Influence: 55.7] [Reference Citation Analysis]
615 Anthony PP. Hepatocellular carcinoma: an overview. Histopathology. 2001;39:109-118. [PMID: 11493326 DOI: 10.1046/j.1365-2559.2001.01188.x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 72] [Article Influence: 4.6] [Reference Citation Analysis]
616 Okuda K. Hepatocellular carcinoma. J Hepatol. 2000;32:225-237. [PMID: 10728807 DOI: 10.1016/s0168-8278(00)80428-6] [Cited by in Crossref: 380] [Cited by in F6Publishing: 124] [Article Influence: 18.1] [Reference Citation Analysis]
617 Weggen S, Bayer TA, von Deimling A, Reifenberger G, von Schweinitz D, Wiestler OD, Pietsch T. Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas. Brain Pathol 2000;10:85-92. [PMID: 10668898 DOI: 10.1111/j.1750-3639.2000.tb00245.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 2.8] [Reference Citation Analysis]
618 McCullough AJ, Falck-Ytter Y. Body composition and hepatic steatosis as precursors for fibrotic liver disease. Hepatology. 1999;29:1328-1330. [PMID: 10094983 DOI: 10.1002/hep.510290451] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 2.3] [Reference Citation Analysis]
619 García-retortillo M, Forns X. Variabilidad genómica e historia natural de la infección por el virus de la hepatitis C. Gastroenterología y Hepatología 2002;25:514-20. [DOI: 10.1016/s0210-5705(02)70303-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
620 Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002;36:1206-13. [PMID: 12395331 DOI: 10.1053/jhep.2002.36780] [Cited by in Crossref: 519] [Cited by in F6Publishing: 450] [Article Influence: 27.3] [Reference Citation Analysis]
621 Wang Y, Kato N, Jazag A, Dharel N, Otsuka M, Taniguchi H, Kawabe T, Omata M. Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response. Gastroenterology. 2006;130:883-892. [PMID: 16530526 DOI: 10.1053/j.gastro.2005.12.028] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 5.3] [Reference Citation Analysis]
622 Moriishi K. The potential of signal peptide peptidase as a therapeutic target for hepatitis C. Expert Opinion on Therapeutic Targets 2017;21:827-36. [DOI: 10.1080/14728222.2017.1369959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
623 Tellinghuisen TL, Rice CM. Interaction between hepatitis C virus proteins and host cell factors. Curr Opin Microbiol. 2002;5:419-427. [PMID: 12160863 DOI: 10.1016/s1369-5274(02)00341-7] [Cited by in Crossref: 135] [Cited by in F6Publishing: 56] [Article Influence: 7.1] [Reference Citation Analysis]
624 Cho K, Ro SW, Seo SH, Jeon Y, Moon H, Kim DY, Kim SU. Genetically Engineered Mouse Models for Liver Cancer. Cancers (Basel) 2019;12:E14. [PMID: 31861541 DOI: 10.3390/cancers12010014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
625 Khaliq S, Jahan S, Ijaz B, Ahmad W, Asad S, Pervaiz A, Samreen B, Khan M, Hassan S. Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs. Virol J 2010;7:318. [PMID: 21073745 DOI: 10.1186/1743-422X-7-318] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
626 Zeuzem. Treatment of chronic hepatitis C virus infection in patients with cirrhosis. J Viral Hepat 2000;7:327-34. [DOI: 10.1046/j.1365-2893.2000.00229.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
627 Liu M, Ding H, Zhao P, Qin ZL, Gao J, Cao MM, Luan J, Wu WB, Qi ZT. RNA interference effectively inhibits mRNA accumulation and protein expression of hepatitis C virus core and E2 genes in human cells. Biosci Biotechnol Biochem. 2006;70:2049-2055. [PMID: 16960393 DOI: 10.1271/bbb.60001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
628 Lewis S, Roayaie S, Ward SC, Shyknevsky I, Jibara G, Taouli B. Hepatocellular carcinoma in chronic hepatitis C in the absence of advanced fibrosis or cirrhosis. AJR Am J Roentgenol. 2013;200:W610-W616. [PMID: 23701091 DOI: 10.2214/ajr.12.9151] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.9] [Reference Citation Analysis]
629 Tsutsumi T, Suzuki T, Moriya K, Shintani Y, Fujie H, Miyoshi H, Matsuura Y, Koike K, Miyamura T. Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice. Hepatology. 2003;38:820-828. [PMID: 14512869 DOI: 10.1002/hep.1840380408] [Cited by in Crossref: 53] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
630 Carloni G, Fioretti D, Rinaldi M, Ponzetto A. Heterogeneity and coexistence of oncogenic mechanisms involved in HCV-associated B-cell lymphomas. Crit Rev Oncol Hematol 2019;138:156-71. [PMID: 31092372 DOI: 10.1016/j.critrevonc.2019.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
631 Rajlawot K, Jiang T, Zhou J, Lin C, Kuang S, Chen J, Zhang Y, Yang H, Deng Y, He B, Hernando D, Reeder SB, Wang J. Accuracies of Chemical Shift In/Opposed Phase and Chemical Shift Encoded Magnetic Resonance Imaging to Detect Intratumoral Fat in Hepatocellular Carcinoma. J Magn Reson Imaging 2021;53:1791-802. [PMID: 33580551 DOI: 10.1002/jmri.27539] [Reference Citation Analysis]
632 Ezzikouri S, El Feydi AE, Chafik A, Afifi R, El Kihal L, Benazzouz M, Hassar M, Pineau P, Benjelloun S. Genetic polymorphism in the manganese superoxide dismutase gene is associated with an increased risk for hepatocellular carcinoma in HCV-infected Moroccan patients. Mutat Res 2008;649:1-6. [PMID: 18023606 DOI: 10.1016/j.mrgentox.2007.05.019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
633 Komposch K, Sibilia M. EGFR Signaling in Liver Diseases. Int J Mol Sci 2015;17:E30. [PMID: 26729094 DOI: 10.3390/ijms17010030] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 12.7] [Reference Citation Analysis]
634 de Souza TLF, de Lima SMB, Braga VLA, Peabody DS, Ferreira DF, Bianconi ML, Gomes AMO, Silva JL, de Oliveira AC. Charge neutralization as the major factor for the assembly of nucleocapsid-like particles from C-terminal truncated hepatitis C virus core protein. PeerJ 2016;4:e2670. [PMID: 27867765 DOI: 10.7717/peerj.2670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
635 Pawlotsky JM, Germanidis G. The non-structural 5A protein of hepatitis C virus. J Viral Hepat 1999;6:343-56. [PMID: 10607250 DOI: 10.1046/j.1365-2893.1999.00185.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 1.7] [Reference Citation Analysis]
636 Nakamura H, Aoki H, Hino O, Moriyama M. HCV core protein promotes heparin binding EGF-like growth factor expression and activates Akt. Hepatol Res 2011;41:455-62. [PMID: 21418450 DOI: 10.1111/j.1872-034X.2011.00792.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
637 Yano Y, Yamashita F, Kuwaki K, Fukumori K, Kato O, Yamamoto H, Ando E, Tanaka M, Sata M. Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with α-fetoprotein and protein induced by vitamin K absence or antagonist-II. Liver Int 2006;26:789-95. [DOI: 10.1111/j.1478-3231.2006.01310.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
638 Iwai S, Murai T, Makino S, Min W, Morimura K, Mori S, Hagihara A, Seki S, Fukushima S. High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice. Cancer Lett 2007;246:115-21. [PMID: 16569478 DOI: 10.1016/j.canlet.2006.02.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
639 Chang ML, Chen JC, Chang MY, Yeh CT, Lin WP, Liang CK, Huang SF, Dang KN, Chiu CT, Lin DY. Acute expression of hepatitis C core protein in adult mouse liver: Mitochondrial stress and apoptosis. Scand J Gastroenterol. 2008;43:747-755. [PMID: 18569993 DOI: 10.1080/00365520701875987] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
640 Jin DY, Wang HL, Zhou Y, Chun AC, Kibler KV, Hou YD, Kung H, Jeang KT. Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO J. 2000;19:729-740. [PMID: 10675342 DOI: 10.1093/emboj/19.4.729] [Cited by in Crossref: 91] [Cited by in F6Publishing: 92] [Article Influence: 4.3] [Reference Citation Analysis]
641 Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol. 2000;33:282-289. [PMID: 10952246 DOI: 10.1016/s0168-8278(00)80369-4] [Cited by in Crossref: 171] [Cited by in F6Publishing: 44] [Article Influence: 8.1] [Reference Citation Analysis]
642 Okamoto K, Moriishi K, Miyamura T, Matsuura Y. Intramembrane proteolysis and endoplasmic reticulum retention of hepatitis C virus core protein. J Virol 2004;78:6370-80. [PMID: 15163730 DOI: 10.1128/JVI.78.12.6370-6380.2004] [Cited by in Crossref: 75] [Cited by in F6Publishing: 52] [Article Influence: 4.4] [Reference Citation Analysis]
643 Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Sakamoto K, Hamada K, Ishitsuka H, Miyamoto T, Uchimura S, Hamamoto Y. Self-organizing-map-based molecular signature representing the development of hepatocellular carcinoma. FEBS Lett 2005;579:1089-100. [PMID: 15710396 DOI: 10.1016/j.febslet.2004.10.113] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
644 Hashimoto Y, Ochi H, Abe H, Hayashida Y, Tsuge M, Mitsui F, Hiraga N, Imamura M, Takahashi S, Nelson Hayes C, Ohishi W, Kubo M, Tsunoda T, Kamatani N, Nakamura Y, Chayama K. Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b. J Med Virol 2011;83:981-8. [DOI: 10.1002/jmv.22028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
645 Tsukiyama-kohara K, Toné S, Maruyama I, Inoue K, Katsume A, Nuriya H, Ohmori H, Ohkawa J, Taira K, Hoshikawa Y, Shibasaki F, Reth M, Minatogawa Y, Kohara M. Activation of the CKI-CDK-Rb-E2F Pathway in Full Genome Hepatitis C Virus-expressing Cells. Journal of Biological Chemistry 2004;279:14531-41. [DOI: 10.1074/jbc.m312822200] [Cited by in Crossref: 52] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
646 Butt AS, Sharif F, Abid S. Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon? World J Hepatol 2018;10:267-76. [PMID: 29527262 DOI: 10.4254/wjh.v10.i2.267] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
647 Bhattacharya R, Shuhart MC. Hepatitis C and Alcohol: Interactions, Outcomes, and Implications. Journal of Clinical Gastroenterology 2003;36:242-52. [DOI: 10.1097/00004836-200303000-00012] [Cited by in Crossref: 106] [Cited by in F6Publishing: 86] [Article Influence: 5.9] [Reference Citation Analysis]
648 Wu Q, Liu Q. Do hepatitis B virus and hepatitis C virus co-infections increase hepatocellular carcinoma occurrence through synergistically modulating lipogenic gene expression?: HBV HCV co-infection and HCC. Hepatology Research 2012;42:733-40. [DOI: 10.1111/j.1872-034x.2012.00994.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
649 Yu H, Li M, He R, Fang P, Wang Q, Yi Y, Wang F, Zhou L, Zhang Y, Chen A, Peng N, Liu D, Trilling M, Broering R, Wiemer EAC, Lu M, Zhu Y, Liu S. Major Vault Protein Promotes Hepatocellular Carcinoma Through Targeting Interferon Regulatory Factor 2 and Decreasing p53 Activity. Hepatology 2020;72:518-34. [PMID: 31758709 DOI: 10.1002/hep.31045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
650 Dhanasekaran R, Nault JC, Roberts LR, Zucman-Rossi J. Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy. Gastroenterology 2019;156:492-509. [PMID: 30404026 DOI: 10.1053/j.gastro.2018.11.001] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 21.7] [Reference Citation Analysis]
651 Iwasa J, Shimizu M, Shiraki M, Shirakami Y, Sakai H, Terakura Y, Takai K, Tsurumi H, Tanaka T, Moriwaki H. Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice. Cancer Sci 2010;101:460-7. [PMID: 19906067 DOI: 10.1111/j.1349-7006.2009.01402.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
652 Xu K, Deng XY, Yue Y, Guo ZM, Huang B, Hong X, Xiao D, Chen XG. Generation of the regulatory protein rtTA transgenic mice. World J Gastroenterol 2005;11:2885-91. [PMID: 15902723 DOI: 10.3748/wjg.v11.i19.2885] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
653 Negro F. Mechanisms and significance of liver steatosis in hepatitis C virus infection. World J Gastroenterol. 2006;12:6756-6765. [PMID: 17106922 DOI: 10.3748/wjg.v12.i42.6756] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 90] [Article Influence: 7.4] [Reference Citation Analysis]
654 Jia F, Diao P, Wang X, Hu X, Kimura T, Nakamuta M, Nakamura I, Shirotori S, Sato Y, Moriya K, Koike K, Gonzalez FJ, Nakayama J, Aoyama T, Tanaka N. Dietary Restriction Suppresses Steatosis-Associated Hepatic Tumorigenesis in Hepatitis C Virus Core Gene Transgenic Mice. Liver Cancer 2020;9:529-48. [PMID: 33083279 DOI: 10.1159/000508308] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
655 Ripoli M, Barbano R, Balsamo T, Piccoli C, Brunetti V, Coco M, Mazzoccoli G, Vinciguerra M, Pazienza V. Hypermethylated levels of E-cadherin promoter in Huh-7 cells expressing the HCV core protein. Virus Res. 2011;160:74-81. [PMID: 21640770 DOI: 10.1016/j.virusres.2011.05.014] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
656 Tsukiyama-Kohara K, Sekiguchi S, Kasama Y, Salem NE, Machida K, Kohara M. Hepatitis C virus-related lymphomagenesis in a mouse model. ISRN Hematol 2011;2011:167501. [PMID: 22084693 DOI: 10.5402/2011/167501] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
657 Moriishi K, Okabayashi T, Nakai K, Moriya K, Koike K, Murata S, Chiba T, Tanaka K, Suzuki R, Suzuki T. Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein. J Virol. 2003;77:10237-10249. [PMID: 12970408 DOI: 10.1128/jvi.77.19.10237-10249.2003] [Cited by in Crossref: 118] [Cited by in F6Publishing: 66] [Article Influence: 6.6] [Reference Citation Analysis]
658 Hézode C, Roudot-Thoraval F, Zafrani ES, Dhumeaux D, Pawlotsky JM. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections. J Viral Hepat. 2004;11:455-458. [PMID: 15357652 DOI: 10.1111/j.1365-2893.2004.00528.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 4.5] [Reference Citation Analysis]
659 Sato K, Misawa N, Nie C, Satou Y, Iwakiri D, Matsuoka M, Takahashi R, Kuzushima K, Ito M, Takada K, Koyanagi Y. A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice. Blood 2011;117:5663-73. [PMID: 21467545 DOI: 10.1182/blood-2010-09-305979] [Cited by in Crossref: 77] [Cited by in F6Publishing: 68] [Article Influence: 7.7] [Reference Citation Analysis]
660 Ito S, Hirabayashi K, Moriishi K, Matsui Y, Moriya K, Koike K, Matsuura Y, Shiota K, Yagi S. Novel sex-dependent differentially methylated regions are demethylated in adult male mouse livers. Biochem Biophys Res Commun 2015;462:332-8. [PMID: 25960295 DOI: 10.1016/j.bbrc.2015.04.137] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
661 Messerini L, Novelli L, Comin CE. Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma. J Clin Pathol. 2004;57:867-871. [PMID: 15280410 DOI: 10.1136/jcp.2003.015784] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 3.2] [Reference Citation Analysis]
662 Levrero M. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 2006;25:3834-47. [DOI: 10.1038/sj.onc.1209562] [Cited by in Crossref: 278] [Cited by in F6Publishing: 258] [Article Influence: 18.5] [Reference Citation Analysis]
663 Nita ME, Alves VA, Carrilho FJ, Ono-Nita SK, Mello ES, Gama-Rodrigues JJ. Molecular aspects of hepatic carcinogenesis. Rev Inst Med Trop Sao Paulo. 2002;44:39-48. [PMID: 11896411 DOI: 10.1590/s0036-46652002000100007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
664 Sällberg M, Frelin L, Weiland O. DNA vaccine therapy for chronic hepatitis C virus (HCV) infection: immune control of a moving target. Expert Opin Biol Ther 2009;9:805-15. [PMID: 19527105 DOI: 10.1517/14712590902988444] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
665 Macdonald GA. Hepatocellular carcinoma: . Current Opinion in Gastroenterology 1999;15:253-9. [DOI: 10.1097/00001574-199905000-00011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
666 Munakata T, Nakamura M, Liang Y, Li K, Lemon SM. Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase. Proc Natl Acad Sci USA. 2005;102:18159-18164. [PMID: 16332962 DOI: 10.1073/pnas.0505605102] [Cited by in Crossref: 96] [Cited by in F6Publishing: 84] [Article Influence: 6.0] [Reference Citation Analysis]
667